Diseases
Uterine Cervical NeoplasmsPancreatic Neoplasms
Uterine Cervical Neoplasms
Tumors or cancer of the UTERINE CERVIX.
Pancreatic Neoplasms
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. (1/6661)

AIM: To test a new assay for the detection of human papillomavirus (HPV) DNA, hybrid capture II (HC II), compared with the previous commercialized hybrid capture I (HC I) and polymerase chain reaction (PCR) results on cervical scrapes from fresh cone excision biopsy samples. METHODS: The three methods were used on cervical scrapes from 42 fresh cone excision biopsy samples. There were nine metaplastic and inflammatory lesions, five low grade lesions, and 28 high grade lesions. PCR was performed using the general primers GP5+/GP6+. The viral load of high risk HPV DNA was estimated by the ratio of relative light units to positive control values in the samples. RESULTS: The sensitivity of HC I for the detection of high grade lesions was 71.4%, while it was 92.8% for HC II and 96.4% for the PCR. Considering only the absence of detectable cervical in situ neoplasia, the specificity was 88.9% for HC I, 66.7% for HC II, and 66.7% for PCR. With HC II, for a ratio of cervical sample to normal control of > 200, the sensitivity for the detection of high grade lesion was only 34.6% with a specificity of 66.7%. CONCLUSIONS: HPV detection with the HC II assay is more sensitive than the previous HC I and represents a more convenient and easier test than PCR for routine use. Nevertheless the viral load estimated with this test cannot be a reliable predictive indicator of high grade lesions.  (+info)

Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection. (2/6661)

AIM: To investigate the immunocytochemical staining pattern of mdm2 and p21WAF1 proteins in invasive cervical cancer and to determine its relation with the expression of p53 and with the high risk HPV infection. METHODS: Immunocytochemistry for p53, mdm2, and p21WAF1 was performed in 31 paraffin embedded sections of invasive cervical cancer. The results were assessed by image analysis, evaluating for each protein the optical density of the immunostained area, scored as percentage of the total nuclear area. The presence of high risk human papillomavirus (HPV) infection was detected by using the polymerase chain reaction. RESULTS: Immunostaining for both mdm2 and p21WAF1 was correlated with p53 expression; however, the correlation between p53 and mdm2 (R = 0.49; p < 0.01) was more significant than between p53 and p21WAF1 (R = 0.31; p < 0.05); the less stringent correlation between p53 and p21WAF1 might reflect the p53 independent mechanisms of p21WAF1 induction. Similar average levels of p53, mdm2, and p21WAF1 immunostaining were found in the presence or absence of high risk HPV-DNA, without significant differences between the two groups. CONCLUSIONS: These data suggest that mdm2 and p21WAF1 proteins are expressed in invasive cervical cancer and that their immunocytochemical staining pattern is not abrogated by the presence of high risk HPV genomic sequences.  (+info)

Expression of extracellular matrix proteins in cervical squamous cell carcinoma--a clinicopathological study. (3/6661)

AIM: To evaluate the intracellular and peritumoral expression of matrix proteins in squamous cell carcinoma of the uterine cervix using immunohistochemistry. METHODS: 71 squamous cell carcinomas and 10 controls were stained for laminin, fibronectin, and collagen IV. Cytoplasmic staining in tumour cells and peritumoral deposition of matrix proteins were evaluated. The association between staining results and patient age, tumour stage, histological grade, and survival was studied. RESULTS: Positive cytoplasmic staining for laminin, fibronectin, and collagen IV was observed in 17 (23.9%), 27 (38%), and 10 (14.1%) cases, respectively. Staining for laminin was most pronounced in the invasive front of tumour islands, while for fibronectin and collagen IV it appeared to be diffuse. Peritumoral staining for laminin and collagen IV was detected in 12 cases (16.9%). Early stage (Ia1-Ia2) tumours were uniformly negative for all three proteins. Cytoplasmic staining for laminin correlated with positive staining for fibronectin and collagen IV, and with the presence of a peritumoral deposition of collagen IV and laminin. There was no correlation with any of the three markers between staining results and patient age, stage, grade, or survival. CONCLUSIONS: Expression of extracellular matrix proteins in some cervical squamous cell carcinomas might reflect the enhanced ability of these tumours to modify the peritumoral stroma. This ability seems to be absent in early stage tumours. The correlation between intracytoplasmic and peritumoral expression of matrix proteins supports the evidence of their synthesis by tumour cells. However, this property did not correlate with disease outcome in this study.  (+info)

Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour. (4/6661)

The United Kingdom (UK) cervical screening programme has been successful in securing participation of a high proportion of targeted women, and has seen a fall in mortality rates of those suffering from cervical cancer. There remains, however, a significant proportion of unscreened women and, of women in whom an abnormality is detected, many will not attend for colposcopy. The present work reviews the psychological consequences of receiving an abnormal cervical smear result and of secondary screening and treatment, and examines reasons for women's non-participation in the screening programme. Psychological theories of screening behavior are used to elucidate women's reactions and to suggest methods of increasing participation, of improving the quality of the service, and of reducing women's anxiety. A literature search identified studies that examine factors influencing women's participation in the screening programme, their psychological reaction to the receipt of an abnormal cervical smear result, and experiences of colposcopy. Reasons for non-participation include administrative failures, unavailability of a female screener, inconvenient clinic times, lack of awareness of the test's indications and benefits, considering oneself not to be at risk of developing cervical cancer, and fear of embarrassment, pain, or the detection of cancer. The receipt of an abnormal result and referral for colposcopy cause high levels of distress owing to limited understanding of the meaning of the smear test; many women believe the test aims to detect existing cervical cancer. The quality of the cervical screening service can be enhanced by the provision of additional information, by improved quality of communication, and by consideration of women's health beliefs. This may result in increased participation in, and satisfaction with, the service.  (+info)

Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers. (5/6661)

Carcinoma of the uterine cervix is a common malignancy among women that has been found to show loss of heterozygosity in the chromosome 11p. Recent studies have localized the TSG101 gene in this region, and also demonstrated a high frequency of abnormalities of this gene in human breast cancer. To determine the role of the TSG101 gene in the carcinogenesis of cervical and uterine carcinoma, 19 cases of cervical carcinoma and five cases of endometrial carcinoma, as well as nearby non-cancerous tissue from the same patients, and 16 blood samples from healthy persons as normal control were analysed by Southern blot analysis of genomic DNA, reverse transcription of the TSG101 mRNA followed by PCR amplification and sequencing of the products. We found that abnormal transcripts of the TSG101 gene were common both in cancerous or non-cancerous tissues of the uterus and cervix and in normal peripheral mononuclear cells. There was no genomic deletion or rearrangement in spite of the presence of abnormal transcripts, and no definite relationship between the abnormal transcripts and HPV infection was found. Although the frequency of abnormal transcripts was higher in cancerous than in non-cancerous tissue, normal peripheral mononuclear cells also had abnormal transcripts. Given these findings, the role of the TSG101 gene as a tumour-suppressor gene should be re-evaluated. Because some aberrant transcripts could be found at the first PCR reaction, we suggest that the aberrant transcripts might be the result of imperfect minor splicesome products.  (+info)

A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix. (6/6661)

To investigate involvement of an aberrant expression of the FHIT (fragile histidine triad) gene in the process of carcinogenesis and progression in cervical carcinoma, we examined its expression by the reverse transcriptase polymerase chain reaction (RT-PCR) and cDNA sequence method in 32 cervical invasive carcinomas (25 squamous cell carcinomas and seven adeno- or adenosquamous carcinomas) and 18 of its precursor lesions [four low-grade and 14 high-grade cervical intraepithelial neoplasias (CINs)]. We also examined a link between the occurrence of the aberrant expression and human papillomavirus (HPV). We detected the aberrant FHIT transcripts in 11 of 25 (44%) cervical invasive squamous cell carcinomas and in 5 of 14 (36%) high-grade CINs (CIN 2 or 3), whereas they were not found in seven non-squamous type and four low-grade CINs (CIN 1). The alteration patterns of the FHIT gene expression in high-grade CINs were virtually similar to those found in invasive carcinomas, such that the exons 5-7 were consistently deleted associated or unassociated with loss of the exon 4 and/or 8. The incidence of the aberrant expression was not related to the presence of HPV and its type. These data indicate that the aberrant expression of the FHIT gene is observed in precursor lesions of cervical carcinoma as well as invasive carcinomas, with its incidence not increasing with advance of clinical stage. Given the squamous cell type dominant expression, the aberrant expression may play a critical role in the generation of squamous cell carcinoma of the uterine cervix, but not the consequence of the progression of the cancer.  (+info)

Modulation of the cytotoxicity of 3'-azido-3'-deoxythymidine and methotrexate after transduction of folate receptor cDNA into human cervical carcinoma: identification of a correlation between folate receptor expression and thymidine kinase activity. (7/6661)

Cervical carcinoma is an AIDS-defining illness. The expression of folate receptors (FRs) in cervical carcinoma (HeLa-IU1) cells was modulated by stable transduction of FR cDNA encapsidated in recombinant adeno-associated virus-2 in the sense and antisense orientation (sense and antisense cells, respectively). Although sense cells proliferated slower than antisense or untransduced cells in vivo and in vitro in 2% (but not 10%) FCS, [methyl-3H]thymidine incorporation into DNA was significantly increased in sense cells in 10% serum; therefore, the basis for this discrepancy was investigated. The activity of thymidine kinase (TK) was subsequently directly correlated with the extent of FR expression in single cell-derived clones of transduced cells. This elevated TK activity was not a result of recruitment of the salvage pathway based on the presence of adequate dTTP pools, normal thymidylate synthase (TS) activity, persistence of increased thymidine incorporation despite the exogenous provision of excess 5,10-methylene-tetrahydrofolate, and documentation of adequate folates in sense cells. The increase in TK activity conferred significant biological properties to sense cells (but not antisense or untransduced cells) as demonstrated by augmented phosphorylation of 3'-azido-3'-deoxythymidine (AZT) and concomitantly greater sensitivity to the cytotoxic effects of AZT. Conversely, sense cells were highly resistant to methotrexate, but this was reversed by the addition of AZT. The direct correlation of FR expression and TK activity indicates a previously unrecognized consequence of FR overexpression.  (+info)

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. (8/6661)

BACKGROUND: Human papillomavirus (HPV) infection is associated with precancerous cervical squamous intraepithelial lesions commonly seen among women infected with human immunodeficiency virus-1 (HIV). We characterized HPV infection in a large cohort of HIV-positive and HIV-negative women participating in the Women's Interagency HIV Study to determine the prevalence of and risk factors for cervicovaginal HPV infection in HIV-positive women. METHODS: HIV-positive (n = 1778) and HIV-negative (n = 500) women were tested at enrollment for the presence of HPV DNA in a cervicovaginal lavage specimen. Blood samples were tested for HIV antibody status, level of CD4-positive T cells, and HIV RNA load (copies/mL). An interview detailing risk factors was conducted. Univariate and multivariate analyses were performed. RESULTS: Compared with HIV-negative women, HIV-positive women with a CD4+ cell count of less than 200/mm3 were at the highest risk of HPV infection, regardless of HIV RNA load (odds ratio [OR] = 10.13; 95% confidence interval [CI] = 7.32-14.04), followed by women with a CD4+ count greater than 200/mm3 and an HIV RNA load greater than 20,000 copies/mL (OR = 5.78; 95% CI = 4.17-8.08) and women with a CD4+ count greater than 200/mm3 and an HIV RNA load less than 20,000 copies/mL (OR = 3.12; 95% CI = 2.36-4.12), after adjustment for other factors. Other risk factors among HIV-positive women included racial/ethnic background (African-American versus Caucasian, OR = 1.64; 95% CI = 1.19-2.28), current smoking (yes versus no; OR = 1.55; 95% CI = 1.20-1.99), and younger age (age < 30 years versus > or = 40 years; OR = 1.75; 95% CI = 1.23-2.49). CONCLUSIONS: Although the strongest risk factors of HPV infection among HIV-positive women were indicators of more advanced HIV-related disease, other factors commonly found in studies of HIV-negative women, including racial/ethnic background, current smoking, and age, were important in HIV-positive women as well.  (+info)

Vitamin or Antioxidant Intake May Reduce the Risk of Cervical Neoplasm : Terry Talks NutritionVitamin or Antioxidant Intake May Reduce the Risk of Cervical Neoplasm : Terry Talks Nutrition
In this meta-analysis which included data gathered from 22 case-control studies, involving a total of 10,073 subjects, which investigated an association between vitamin or antioxidant intake (or serum level) and cervical neoplasm risk, results found that intakes of vitamin B12 (OR=0.35), vitamin C (OR=0.67), vitamin E (OR=0.56), and beta-carotene (OR=0.68) were found to be associated with a significantly reduced odds ratio of cervical neoplasm. The authors state, The findings of this meta-analysis indicate that overall, there were preventive effects of vitamin or antioxidant intake on cervical neoplasms in case-control studies.. Click Here to visit the journal website. Subscription required to view the full text of the article.. ...
https://www.terrytalksnutrition.com/study-spotlight/vitamin-or-antioxidant-intake-may-reduce-the-risk-of-cervical-neoplasm/
The m 6 A eraser FTO facilitates proliferation and migration of human cervical cancer cells | Cancer Cell International | Full...The m 6 A eraser FTO facilitates proliferation and migration of human cervical cancer cells | Cancer Cell International | Full...
Since FTO was recognized as the first m6A demethylase, the understanding of its biological function has been widely expanded. However, the role of FTO in cervical cancer tumorigenesis remains unclear. In this study, we first analyzed the expression of FTO in two independent human cancer datasets and evaluated the correlation between FTO level and cervical cancer progression. Using small hairpin RNA technology, we explored the function of FTO in cervical cancer cell line Hela and SiHa cells, respectively. We then determined the FTO targets by performing transcriptional profile with FTO deficient and competent Hela cells, and finally validated these targets with ribosome profiling and functional rescue experiments. Our data suggested that FTO was frequently overexpressed in human cervical cancer tissues and highly correlated with cervical cancer progression. FTO serves as an oncogenic regulator for cervical cancer cells proliferation and migration which is vastly depended on its demethylase activity.
https://cancerci.biomedcentral.com/articles/10.1186/s12935-019-1045-1/email/correspondent/c2/new
北京大学医学部机构知识库([email protected]): E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours
A previous study showed E-cadherin expression was lost in some cervical cancer cell lines and tumours. This study was designed to clarify the significance of DNA methylation in silencing E-cadherin expression. We examined promoter methylation of E-cadherin in five cervical cancer cell lines and 20 cervical cancer tissues using methylation-specific PCR (MSP) and bisulphite DNA sequencing. The correlation of E-cadherin methylation and expression together with methyltransferase (DNMT1) were further studied. We found that hypermethylation of E-cadherin was involved in five cervical cancer cell lines and 40% (8/20) of cervical cancer tissues. E-cadherin protein was lost in 6/8 (75%) samples and 3/5 (60%) cell lines with promoter methylation. E-cadherin methylation was significantly correlated with increased DNMT1. Using an antisense DNMT1 oligo to transfect into SiHa HeLa C33A cell line, E-cadherin protein was re-expressed. We concluded that loss of E-cadherin expression was in part correlated with ...
http://ir.bjmu.edu.cn/handle/400002259/62786
Cervical Cancer Treatment Cost in Kolkata & Best Hospitals for Cervical Cancer Treatment in KolkataCervical Cancer Treatment Cost in Kolkata & Best Hospitals for Cervical Cancer Treatment in Kolkata
Searching for the cost of Cervical Cancer Treatment in Kolkata? Contact Lyfboat to Get an Expert Second Opinion and Personalised Quote for Cervical Cancer Treatment from the best Cervical Cancer Treatment hospitals in Kolkata. We enable patients to connect, communicate and find quality healthcare for Cervical Cancer Treatment in Kolkata.
https://www.lyfboat.com/hospitals/cervical-cancer-hospitals-and-costs-in-kolkata/
Gentaur Molecular :US Biomax \ Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical...Gentaur Molecular :US Biomax \ Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical...
Gentaur molecular products has all kinds of products like :search , US Biomax \ Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores; ihc Anti-Actin confirmed \ CR245 for more molecular products just contact us
http://www.antibody-antibodies.com/product_det.php?id=1970634&supplier=search&name=Cervical%20cancer%20tissue%20array%20with%20matched%20adjacent%20cervical%20tissue,%20including%20TNM,%20clinical%20stage%20and%20pathology%20grade,%2012%20cases_24%20cores%3B%20ihc%20%20Anti_Actin%20confirmed
Lymph node-positive, early stage cervical cancer - - GEO DataSets - NCBILymph node-positive, early stage cervical cancer - - GEO DataSets - NCBI
Analysis of primary cervical cancer tissue of patients with pelvic lymph node metastasis. Positive lymph nodes are an important prognostic factor in early-stage cervical cancer patients. Results provide insight into the molecular basis of pelvic lymph node metastasis in early cervical cancer ...
https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/gds?LinkName=geoprofiles_gds&from_uid=101367428
WHO | Comprehensive cervical cancer controlWHO | Comprehensive cervical cancer control
This publication, Comprehensive cervical cancer control: a guide to essential practice (C4GEP), gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the need for collaboration across programmes, organizations and partners. This new guide updates the 2006 edition and includes the recent promising developments in technologies and strategies that can address the gaps between the needs for and availability of services for cervical cancer prevention and control. ...
http://www.who.int/reproductivehealth/publications/cancers/cervical-cancer-guide/en/
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer...Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer...
Our study aimed to provide health economic data to inform the development of the Hungarian cervical cancer prevention program. First, the national program needs to address the problem of the inefficiency of the current screening program [5, 6]. We have previously developed a health economic model to support this decision making process [7]. Furthermore, with the introduction of vaccination against cervical cancer, a new policy question was raised: whether to include the vaccination of adolescent girls in the cervical cancer prevention program. We aimed to analyze this question from a health economic perspective.. Our modeling results predicted that adding vaccination of adolescent girls with the AS04-adjuvanted human papillomavirus 16/18 vaccine to the national cervical cancer screening program would be cost-effective in Hungary. Although our results were quite robust to the uncertainty in the input parameters, larger changes in the most influential parameters could considerably change the ...
https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-12-924
Expression of Fas Ligand is Higher in Early Stage Cervical Cancer with Lymph Nodes Metastasis<...
TY - JOUR. T1 - Expression of Fas Ligand is Higher in Early Stage Cervical Cancer with Lymph Nodes Metastasis. AU - Irwanto, Yahya. AU - Purwoto, Gatot. AU - Sutrisna, Bambang. AU - Rustamadji, Primariadewi. PY - 2012/10. Y1 - 2012/10. N2 - Objective: To know whether the expression of Fas Ligand has correlation with incidene of metastasis of pelvic lymph node and lymph-vascular stromal invasion (LVSI). Methods: All patients diagnosed of cervical cancer stage IB or IIA who underwent radical hysterectomy in Dr. Cipto Mangunkusumo Central General Hospital from January 2008 until December 2009 were included in analytic cross sectional study. We tested expression of Fas Ligand in cervical cancer specimen by immunohystochemistry with monoclonal antibody. The expression of Fas Ligand was compared between the group of patients with a positive and negative pelvic lymph node and between LVSI positive and negative. The difference of expression in both group were statistically analized with Chi-square test ...
https://scholar.ui.ac.id/en/publications/expression-of-fas-ligand-is-higher-in-early-stage-cervical-cancer
Surprising Research on Early-Stage Cervical Cancer Treatment | CTCASurprising Research on Early-Stage Cervical Cancer Treatment | CTCA
Julian Schink, MD, Chief, CTCA Division of Gynecologic Oncology, discusses recent findings that shed light on early-stage cervical cancer treatments in this Insider article.
https://www.cancercenter.com/community/ctca-in-the-news/2018/11/surprising-research-on-early-stage-cervical-cancer-treatment
HPV Vaccination and the Risk of Invasive Cervical Cancer | Physicians WeeklyHPV Vaccination and the Risk of Invasive Cervical Cancer | Physicians Weekly
Cervical cancer is a malignant tumor of the cervix, a part of the female reproductive tract. Recent studies have found the human papillomavirus (HPV) vaccine to be efficient in preventing high-grade cervical lesions. However, the exact effects and efficacy of the vaccine are not known. This study aims to evaluate the association between quadrivalent HPV vaccination and the risk of invasive cervical cancer.. This study included an open population of 1,672,983 girls and women aged 10-30 years. The researchers evaluated the association between HPV vaccination and the risk of invasive cervical cancer, keeping factors like follow-up and parental characteristics in check. The primary outcome of the study was the subsequent risk of invasive cervical cancer after HPV vaccination.. The included participants were evaluated for cervical cancer until they turned 31. The findings suggested that cervical cancer was reported in 19 women who had undergone quadrivalent HPV vaccination. In comparison, 438 women ...
https://www.physiciansweekly.com/hpv-vaccination-and-the-risk-of-invasive-cervical-cancer/
Cervical Cancer | ZanranCervical Cancer | Zanran
Data & statistics on Cervical Cancer: Incidence of CIN 2/3 Detected Through Screening and Cervical Cancer Incidence Prior to Screening Incidence of CIN 2/3 Detected Through Screening and Cervical Cancer Incidence Prior to Screening. Rates are per 100,000 women undergoing routine cytologic screening for CIN 2/3, and per 100,000 women for cervical cancer. The peak incidence of invasive cervical cancer is observed approximately 25-30 years ..., Executive Summary Acronyms and Abbreviations Introduction 1.1 Background and purpose of this study 1.2 Methodology 1.3 Limitations of the study 1.4 Structure of the report Background 2.1 What is cervical cancer? 2.1.1 Risk factors and causes of cervical cancer 2.1.2 Development of cervical cancer 2.2 Prevention 2.2.1 Primary prevention 2.2.2 Secondary prevention 2.3 Diagnosis 2.3.1 Colposcopy 2.3.2 ..., Health burden of detected cervical intraepithelial neoplasia (CIN) 2 and 3, cervical cancer incidence, and mortality, before prophylactic vaccination and after
http://zanran.com/q/Cervical_Cancer
Estimated Age-specific Cervical Cancer Mortality Rates in the Americas | ZanranEstimated Age-specific Cervical Cancer Mortality Rates in the Americas | Zanran
Data & statistics on Estimated Age-specific Cervical Cancer Mortality Rates in the Americas: Estimated Age-specific Cervical Cancer Mortality Rates in the Americas, 2000*, Calibration results of age-specific incidence and mortality of cervical cancer. The circles and bars represent the observed cancer incidence and mortality from the National Cancer Registry of Taiwan, respectively. The squares and hollow bars represent the predicted cancer incidence and mortality by the Markov model in which the current practice of cervical screening was applied from 30 years of age ..., Estimated age-specific cervical cancer death rate in an unscreened population (per 100,000)...
http://zanran.com/q/Estimated_Age-specific_Cervical_Cancer_Mortality_Rates_in_the_Americas
Cervical Cancer
By Hui Xie-Zukauskas. While cervical cancer is one of the most common cancers in women, it is, thankfully, preventable. But do you know how to prevent cervical cancer? As the saying goes, what you dont know can hurt you. Here are five important approaches to cervical cancer prevention:. 1. Enhance awareness of cervical cancer.. Misconceptions and poor awareness about cervical cancer are common. Poor awareness may result in delayed detection and treatment due to lack of knowledge and motivation, which can promote poor survivorship. During cervical cancer awareness month, find a way to raise your awareness; e.g., read more information or watch videos on cervical cancer (at the CDC website), send this e-Card to loved ones or friends, and/or participate in a public service to spread the word.. 2. Vaccinate girls and boys.. More than 95 % of cervical cancer cases are closely associated with human papillomavirus (HPV) infection. Some types of HPV are also known to cause cancers of the anus, penis, ...
http://www.cancerpreventiondaily.com/tag/cervical-cancer/
Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma. - Semantic ScholarGene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma. - Semantic Scholar
OBJECTIVE The purpose of the study was to investigate benign and malignant squamous cervical cells obtained by cervical swabs with regard to differentially expressed genes and gene expression profiling, in order to evaluate the biological behavior and clinical outcome of cervical malignancies. METHODS Cervical squamous cells from six women with high-risk human papillomavirus positive [HR-HPV(+)] cervical carcinoma and from six HPV-negative women with normal ectocervical cells were analyzed by cDNA array. RESULTS cDNA over-expression of several genes such as MET (c-met), Nm23-H1 (NME1), EGFR, KGFR, Nm23-H2 (NME2), ERBB2 (c-erbB-2), cyclin-dependent kinase inhibitor 4 (CDKN2A, p16INK4A), cytokeratin 8 (KRT8), KRAS (K-ras), FLT1, KGF (FGF7), BCL2-like 2 protein (BCL2L2), ERBB4, MYCN (N-myc), cyclin D1 (CCND1), KIT (c-kit), secreted phosphoprotein 1 (SPP1) and STAT1, was significant in cervical squamous cell carcinoma (CSCC). Gene expression was downregulated for 13 genes in CSCC, such as interleukin 1
https://www.semanticscholar.org/paper/Gene-profiling-in-Pap-cell-smears-of-high-risk-hum-Manavi-Hudelist/a800b0b51be490916f55bd2cafe7157441b39644
Gentaur Molecular :US Biomax \ Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology...Gentaur Molecular :US Biomax \ Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology...
Gentaur molecular products has all kinds of products like :search , US Biomax \ Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases_24 cores, replacing CR241; ihc Anti-Actin confirmed \ CR244 for more molecular products just contact us
http://www.antibody-antibodies.com/product_det.php?id=1970633&supplier=search&name=Uterine%20cervix%20cancer%20tissue%20array,%20with%20adjacent%20normal%20tissue,%20including%20TNM%20and%20pathology%20grade,%2012%20cases_24%20cores,%20replacing%20CR241%3B%20ihc%20%20Anti_Actin%20confirmed
Distribution of HPV-16 Intratypic Variants among Women with Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer in...Distribution of HPV-16 Intratypic Variants among Women with Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer in...
Objectives. Infection with high-risk human papillomavirus (HPV) is a critical factor associated withcarcinogenesis of the uterine cervix. HPV-16 is most frequently found, and is further subclassified into intratypicvariants based on the nucleotide sequences of the viral genes. Although certain HPV-16 variants are reported tobe associated with the progression of cervical lesions, these relationships remain controversial with differentresults for different populations. To provide data for another population, we investigated the prevalence ofHPV-16 and distributions of its intratypic variants among Mongolian women with cervical intraepithelialneoplasia (CIN) and invasive cervical cancer. Materials and Methods. We analyzed samples from 374 randomlyselected women who attended the National Cancer Center of Mongolia between January 2002 and July 2007,including 147 invasive cervical cancer patients, 127 CIN patients and 100 age-matched controls who werecytologically normal. HPV genotyping was initially
http://journal.waocp.org/article_24818.html
Plus itPlus it
Previous studies have described the importance of DNA methylation in human cancers. Recently, an aberrant methylation pattern was found during the multistage pathogenesis of cervical cancer with an increasing trend to methylation with increasing pathological changes (7) . Promoter hypermethylation of various genes is a frequent epigenetic event in cervical carcinoma (6 , 7 , 15) .3 Epigenetic alterations have been successfully used as indicators of neoplastic serum DNA in patients with various carcinomas (16) . To date, no studies have been undertaken to investigate the methylation status of various genes in serum samples of cervical cancer patients. Recently, we identified five genes, namely CALCA, hTERT, MYOD1, PGR, and TIMP3, as being methylated significantly more frequently in cervical cancer tissue than in normal cervical tissue.3 In our study, all of the patients with methylated serum DNA revealed the same methylation pattern in the corresponding cervical cancer tissue, except one patient ...
http://clincancerres.aacrjournals.org/content/10/2/565
Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
article{9e26cd77-e33a-4061-b74b-6dd6a644862d, abstract = {BACKGROUND: Primary cervical screening with both human papillomavirus (HPV) DNA testing and cytological examination of cervical cells with a Pap test (cytology) has been evaluated in randomized clinical trials. Because the vast majority of women with positive cytology are also HPV DNA positive, screening strategies that use HPV DNA testing as the primary screening test may be more effective. METHODS: We used the database from the intervention arm (n = 6,257 women) of a population-based randomized trial of double screening with cytology and HPV DNA testing to evaluate the efficacy of 11 possible cervical screening strategies that are based on HPV DNA testing alone, cytology alone, and HPV DNA testing combined with cytology among women aged 32-38 years. The main outcome measures were sensitivity for detection of cervical intraepithelial neoplasia grade 3 or worse (CIN3+) within 6 months of enrollment or at colposcopy for women with a ...
https://lup.lub.lu.se/search/publication/1289705
Cervix cancer
Cervix cancer does not spread early. It spreads by way of the lymphatic system. Cervix cancer screening should be offered to all women over 25 years. There is limited evidence of benefit from screening in women aged over 60 years, though the likely yield of screening is low in women over age 60 since the incidence of high-grade cervical lesions declines after middle age. Cervix cancer is preceded by cervical intraepithelial neoplasia (CIN). Surgery for CIN is effective at reducing the risk of subsequent invasive carcinoma.
http://hostbiko.global-yes.com/cervix-cancer-a552.html
Cervical Cancer Could All But Disappear in North America by 2040Cervical Cancer Could All But Disappear in North America by 2040
MONDAY, Feb. 3, 2020 (HealthDay News) -- Vaccination and screening could nearly wipe out cervical cancer in North America in the next 20 years and rid the world of the disease within the next century, researchers say.. In a new study, the researchers assessed the potential impacts of the World Health Organizations (WHO) draft strategy for cervical cancer elimination, which calls for 90% of girls to be vaccinated against human papillomavirus (HPV) by 2030.. HPV causes most cervical cancer cases.. The WHO plan also calls for 70% of women to be screened for cervical cancer once or twice in their lifetime, and for 90% of women with precancerous lesions or cervical cancer to receive appropriate treatment.. With HPV vaccination alone, cervical cancer cases would fall 89% within a century in 78 countries hardest-hit by the disease. Thats 60 million cases of cervical cancer prevented, according to the report.. With the added tests and treatment of precancerous lesions, cervical cancer cases would fall ...
http://healthlibrary.vidanthealth.com/Library/DiseasesConditions/Adult/Gynecological/6,754450
Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous cervical cancer. - Semantic ScholarWidespread lymph node metastases in a young woman with FIGO stage IA1 squamous cervical cancer. - Semantic Scholar
BACKGROUND Lymphatic and hematologic metastases are rare in microinvasive cervical cancers (FIGO stage IA1), supporting a role for conservative treatment. Cervical conization followed by prolonged surveillance is an accepted treatment in patients with low-risk features and negative surgical margins. This option is particularly appealing for younger or nulliparous patients, in whom fertility may be highly desired. CASE We report a case of a 22-year-old, HIV-negative female with stage IA1 squamous cell cervical carcinoma who was found to have bilateral lymph node metastases in both pelvic and para-aortic distributions after electing to undergo hysterectomy. CONCLUSION Clinicians treating patients with microinvasive cervical cancer conservatively must be aware of the possibility of lymph node involvement and should consider radiological imaging to look for metastatic disease.
https://www.semanticscholar.org/paper/Widespread-lymph-node-metastases-in-a-young-woman-Argenta-Kubicek/9aeda95d0aa8f5ea643ac8f42b697f9cb1f64c5a
Issues in cervical cancer incidence and treatment in HIV<...
TY - JOUR. T1 - Issues in cervical cancer incidence and treatment in HIV. AU - Einstein, Mark H.. AU - Phaeton, Rebecca. PY - 2010/9/1. Y1 - 2010/9/1. N2 - Purpose of review: Cervical disease burden continues to be especially high in HIV-infected women, even in the era of effective antiretroviral medications. This review discusses the multiple issues surrounding HIV-associated cervical cancer. Also, the unique treatment-related issues in HIV-associated cervical cancer are addressed. Recent findings: The incidence of invasive cervical cancer has remained stable in industrialized nations; however, it is only estimated in developing countries secondary to a relative lack of data collection and registries. Trends in HIV-associated cervical cancer have changed in the highly active antiretroviral therapy (HAART) era. Recent molecular pathways suggest that the natural progression of human papillomavirus infection, the causal agent in all cervical cancers, may be related to immune system dysfunction as ...
https://pennstate.pure.elsevier.com/en/publications/issues-in-cervical-cancer-incidence-and-treatment-in-hiv
my mom having 4th stage cervix carcinoma, suffering from diabetics, please help - Doctors insight on HealthcareMagicmy mom having 4th stage cervix carcinoma, suffering from diabetics, please help - Doctors insight on HealthcareMagic
Question - my mom having 4th stage cervix carcinoma, suffering from diabetics, please help. Ask a Doctor about diagnosis, treatment and medication for Cervical cancer, Ask an Oncologist
http://www.healthcaremagic.com/questions/my-mom-having-4th-stage-cervix-carcinoma-suffering-from-diabetics-please-help/99347
Effects of genistein on anti-tumor activity of cisplatin in human cervical cancer cell linesEffects of genistein on anti-tumor activity of cisplatin in human cervical cancer cell lines
According to the statistics for 2018, cervical cancer is the fourth most common cancer in women worldwide, with 569,847 patients yearly [1]. Patients with cervical cancer who have progressed to an inoperable stage or have experienced recurrence receive widely used anti-cancer chemotherapy and platinum-based chemotherapy [2]. Cisplatin is a platinum-based chemotherapeutic agent that is widely used for the treatment of malignant tumors, such as cervical cancer, lung cancer, and ovarian cancer [3]. Cisplatin mainly induces cross-linking at the N7-position of guanosine, which modifies DNA to induce apoptosis and kill cancer cells [4]. However, the use of cisplatin as a cancer treatment has been limited owing to its serious side effects involving the kidney or hearing impairment and the emergence of resistant cancer cells [5]. In order to overcome anti-cancer drug resistance, high-dose chemotherapy with increasing dose combination therapy that combines several chemotherapy agents, and concurrent ...
https://www.ogscience.org/journal/view.php?number=593
Cervical cancer | Lima Memorial Health System
Worldwide, cervical cancer is the third most common type of cancer in women. It is much less common in the United States because of the routine use of Pap smears.. Cervical cancer starts in the cells on the surface of the cervix. There are two types of cells on the surface of the cervix, squamous and columnar. Most cervical cancers are from squamous cells.. Cervical cancer usually develops slowly. It starts as a precancerous condition called dysplasia. This condition can be detected by a Pap smear and is nearly 100% treatable. It can take years for dysplasia to develop into cervical cancer. Most women who are diagnosed with cervical cancer today have not had regular Pap smears, or they have not followed up on abnormal Pap smear results.. Almost all cervical cancers are caused by human papillomavirus (HPV). HPV is a common virus that is spread through skin-to-skin contact and also by sexual intercourse. There are many different types (strains) of HPV. Some strains lead to cervical cancer. Other ...
https://www.limamemorial.org/health-library/HIE%20Multimedia-TextOnly/1/000893
cervical cancer survival rates nz
Conclusions: Magnetic resonance imaging stage IIB cervical cancers with negative PMI on physical examination should be surgically treated because of better survival rate than FIGO stage IIB cervical … Making an educated treatment decision begins with the stage, or progression, of the disease. In New Zealand, about 160 women develop cervical cancer each year - and about 50 die from it. If the biopsy shows abnormal cells on the surface of the cervix, you may need to have a cone biopsy or loop excision. In early, localized cervical cancer, five-year survival is 92 percent (SEER). Were trying to find your location, please click Allow if your browser is asking for your Objective: To investigate ethnic, socioeconomic, and urban/rural differences in stage at diagnosis and cervical cancer survival in New Zealand. Regular cervical screening is your best protection against developing cervical cancer. When you have either type of hysterectomy, you will also have a: Pelvic lymphadenectomy - removal of ...
https://www.vauhtihanta.fi/yv99h/8e052d-cervical-cancer-survival-rates-nz
LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathwayLncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway
References. 1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9. [ Links ] 2. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16:1-17. [ Links ] 3. Kuglik P, Kasikova K, Smetana J, Vallova V, Lastuvkova A, Moukova L, et al. Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papilloma-virus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas. Neoplasma. 2015;62:130-9. [ Links ] 4. Sharma S, Mandal P, Sadhukhan T, Chowdhury RR, Mondal NR, Chakravarty B, et al. Bridging links between long noncoding RNA HOTAIR and HPV oncoprotein E7 in cervical cancer pathogenesis. Scientific Rep. 2015;5:11724. [ Links ] 5. Hu X-Y, Hou P-F, Li T-T, Quan H-Y, Li M-L, Lin T, et al. The roles of Wnt/β-catenin signaling pathway related lncRNAs in cancer. Int ...
https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100231&lng=es&nrm=iso&tlng=es
Knockdown of Rab5a expression decreases cancer cell motility and invasion through integrin-mediated signaling pathway | Journal...Knockdown of Rab5a expression decreases cancer cell motility and invasion through integrin-mediated signaling pathway | Journal...
Rab GTPases function as modulators in intracellular transport. Rab5a, a member of the Rab subfamily of small GTPases, is an important regulator of vesicle traffic from the plasma membrane to early endosomes. Recent findings have reported that Rab5a gene was involved in the progression of cancer. In the present study, we investigated the effect of Rab5a on cervical cancer invasion and metastasis and the molecular mechanism underlying the involvement of Rab5a. Rab5a expression was assessed by immunohistochemical analysis on a cervical cancer tissue microarray. RNA interference (RNAi) was performed to knock down the endogenous expression of Rab5a gene in HeLa and SiHa cells. Cell motility was evaluated using invasion assay and wound migration assay in vitro. The expression levels of integrin-associated molecules were detected by Western blot and immunofluorescence. We found that Rab5a was expressed at a high level in cervical cancer tissues. Silencing of Rab5a expression significantly decreased cancer cell
https://jbiomedsci.biomedcentral.com/articles/10.1186/1423-0127-18-58
Is PAP smear era coming to an end? | Nowak-Markwitz | Ginekologia PolskaIs PAP smear era coming to an end? | Nowak-Markwitz | Ginekologia Polska
After the discovery of the role human papilloma virus (HPV) plays in cervical cancer development we have witnessed a change in the conception and interpretation of cervical cancer prevention processes. Primary prevention gained a new tool in the form of HPV vaccines. Secondary prevention, which is cervical intraepithelial neoplasia (CIN) detection, acquired a new diagnostic method - HPV test. Studies were initiated in order to determine the usefulness of HPV tests in cervical cancer prevention and screening. They revealed that DNA HPV test used in screening has higher sensitivity in CIN detection than PAP smear and that HPV negative patients are better and longer protected against developing cervical cancer in comparison to women with normal PAP smear results. HPV tests also possess a predictive value, which detects women more susceptible to developing cervical cancer in the future. PAP smear does not have a predictive value; it only detects a presence or absence of neoplasia at this particular ...
https://journals.viamedica.pl/ginekologia_polska/article/view/45637
Prognostic Value of Human Papillomavirus (HPV) Detection in Cervical Intra-epithelial Neoplasia (CIN) Recurrence After...Prognostic Value of Human Papillomavirus (HPV) Detection in Cervical Intra-epithelial Neoplasia (CIN) Recurrence After...
CIN2/3 have been increased for many years and mainly concern women aged 25-29 years. They are subsequent to a persistent HPV infection and are classically treated by conization. Recurrences occur in 7 to 18 % of cases, mainly after CIN3 management during the first 2 years of follow-up. Follow-up is crucial to detect and treat recurrence and to select high risk women who might develop cervical cancer. Colposcopy and cytology have been recommended since 1989 by French ANAES, but these methods have poor sensitivity and specificity. However, DNA HPV testing is more sensitive and has demonstrated a very high negative predictive value, while specificity and positive predictive value remain average. Other HPV markers like genotyping, viral load and integration begin to be used in screening but have not been investigated in CIN2/3 follow-up to assess the values of various HPV markers which predict CIN2/3 recurrence after conization. The primary objective is to describe HPV expression (genotyping, viral ...
https://clinicaltrials.gov/show/NCT01543048
Cervical Cancer Prevention Cyclist Rally - May 28Cervical Cancer Prevention Cyclist Rally - May 28
A non profit organization initially led by the Cervical Cancer Prevention Network (CECAP) for the Cancer Institute Foundation (CIF), Bravehearts is dedicated to raising awareness on cervical cancer prevention. Bravehearts is currently supported by a growing number of women, including prominent personalities such as Abbygale Arenas-de Leon, who is the current president of the organization, Senator Loren Legarda, Pia Magalona, Ellen Tordesillas, Tessa Prieto-Valdes, Jeena Lopez, Maimai Davao, Joyette Jopson and Suzi Entrata.. The organization has held successful seminars and projects with the help of its partner organizations and companies. One of its more prominent events is the biking event, The Tour of Hope (TTOH). The tour was introduced in the Philippines in 2008 through the collaboration of GlaxoSmithKline Philippines and the UP Cancer Institute Foundations Cervical Cancer Prevention (CECAP) network program in strategic partnership with Team Davids Salon, the first all woman sports team in ...
https://www.viloria.net/archives/cervical-cancer-prevention-cyclist-rally-may-28/
Wanderlust: Human Papillomavirus (HPV)Wanderlust: Human Papillomavirus (HPV)
The abnormal readings that predict cervical cancer are called cervical dysplasia, meaning that the cells of the cervix have been altered by the presence of HPV. These readings can be either LGSIL (low-grade squamous intraepithelial lesions) or HGSIL (high-grade squamous intraepithelial lesions). The higher the grade, the more abnormal the cells, and the closer to cancer it is. However, these LGSIL and HGSIL do not mean that cancer is present, only that abnormalities are present that may lead to cancer. When a pap test shows LGSIL or HGSIL, this means that HPV is definitely present, so there is no need to do a specific HPV test. (More on abnormal Pap testing in a later blog post ...
http://veronica-wanderlust.blogspot.com/2012/10/human-papillomavirus-hpv.html?showComment=1494338542701
Health | Healthblast.com - Part 2
Treatment of cervical cancer has special steps not like any cancer nowadays, as its first and most important step is cervical cancer prevention , and then treatment of non- invasive cervical cancer which is called CIN treatment , and finally invasive cervical cancer treatment.. Follow up of these cases is not less important than treatment itself.. Cervical cancer prevention. There are multiple ways to prevent cervical cancer , the most important steps are screening by pap smear in all sexually active women and follow up that screening according to the new guide lines N.B : details n cervical cancer screening , also early detection and treatment of cervical infection with follow up of it can prevent cervical cancer , having protected sexual course also minimize the rate for sexual transmitted disease and so decrease risk for human papilloma virus infection , which is the main cause lead to cancer cervix .. Treatment of CIN( cervical intraepithial neoplasia , pre invasive cancer ...
https://healthblast.com/tag/health/page/2
July 2017 - P12 - Cervical Cancer Diagnosis based on Random Forest
Cervical cancer, with an annually increasing incidence rate, is becoming the leading cause of death among women in China. However, studies have shown that the early detection and accurate diagnosis of cervical cancer contribute to the long survival of cervical cancer patients. The machine learning method is a good substitute for manual diagnosis in the analysis of Pap smear cervical cell images, reflecting its effective and accurate classification. In the present study, a framework for cervical cancer diagnosis is presented based on a random forest (RF) classifier with ReliefF feature selection. Using preprocessing, segmentation, and feature extraction, 20 features were extracted. In the feature selection phase, 20 features were ranked according to weight using ReliefF. In the classification phase, the RF method was used as a classifier, and different dimensions of features were selected to train the classifier. To examine the efficacy of the proposed method, the Herlev data set collected at Herlev
http://ijpe-online.com/july2017-p12.html
Treatment Outcomes and Prognostic Factors of Cervical Cancer at South Egypt Cancer Institute | MedCrave
Majority of the patients (58%) in our study were above 40 years old. Data from cancer registries in developing countries reported the same finding; 80%-90% of women with cervical cancer in the developing countries were above the age of 40 [12]. Eighty percent of women with cervical cancer in developing countries are diagnosed at advanced stages [13]. In our study, 47 patients (56.6%) presented with cervical cancer at stage III and IV, and these results were similar to other reports [14,15]. This might be attributed to the lack of screening services in our country and women tend to seek medical advice only when they have developed symptoms. In England, 23.8% of 382 women were diagnosed in stages III and IV [16] which contributes to the longer survival [17].. Many series reported pelvic failure rate of (20%-25%) and distant failure rate of (10%-25%) after concurrent chemoradiotherapy [18-22]. Our study reported local recurrence rate of 31.2%, and distant metastasis of 20.8%. The high local ...
http://googlescholar.medcraveonline.com/scholars/article_fulltext/1581
Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment | Bentham ScienceCurrent Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment | Bentham Science
Title:Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment. VOLUME: 15 ISSUE: 5. Author(s):J. Han and J. Guo. Affiliation:Department of Obstetrics and Gynecology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, 10 Changjiangzhilu, Daping, Yuzhong District, Chongqing 400042, P.R. China.. Keywords:Cervical cancer, pigment epithelium derived factor, angiogenesis, differentiation, apoptosis, immune, metastasis.. Abstract:Cervical cancer is the second leading gynecological malignancy threat to the health of women in the world. However, few improvements in the efficacy of treatments of cervical cancer have been reported for the recurrent and metastasis patterns. As an endogenous antitumor agent, pigment epithelium derived factor (PEDF) has attracted wide attention, and its sensitivity to estrogen suggests a special role in female tumors, including cervical cancer. This review aims to summarize recent findings, the role ...
http://www.eurekaselect.com/132564/article
Comprehensive evaluation of cervical cancer screening programs: the case of ColombiaComprehensive evaluation of cervical cancer screening programs: the case of Colombia
Cervical cancer incidence and mortality have been reduced up to 80% in developed countries.1 Despite the absence of clinical trials, the relation between Pap-smear screening and reduction of cervical cancer incidence and mortality has been recognized.2. The decreased burden of disease has been attributed to screening coverage leading to increased effort for extending conventional cytology to all women worldwide. Although screening programs have been successful in developed nations, they have not fulfilled their objectives in the majority of developing countries.1,3 In Colombia, cervical cancer remains the first cause of cancer mortality and the second cause of cancer incidence among women.4. The lack of impact of conventional cytology in low and middle income countries has been linked to social and economic factors as well as deficiencies in program organization.5 Recent studies revealed that Pap-smear coverage does not correlate with trends of cervical cancer mortality in Latin America; ...
http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342011000600002&lng=es&nrm=iso&tlng=en
Comprehensive evaluation of cervical cancer screening programs: the case of ColombiaComprehensive evaluation of cervical cancer screening programs: the case of Colombia
Cervical cancer incidence and mortality have been reduced up to 80% in developed countries.1 Despite the absence of clinical trials, the relation between Pap-smear screening and reduction of cervical cancer incidence and mortality has been recognized.2. The decreased burden of disease has been attributed to screening coverage leading to increased effort for extending conventional cytology to all women worldwide. Although screening programs have been successful in developed nations, they have not fulfilled their objectives in the majority of developing countries.1,3 In Colombia, cervical cancer remains the first cause of cancer mortality and the second cause of cancer incidence among women.4. The lack of impact of conventional cytology in low and middle income countries has been linked to social and economic factors as well as deficiencies in program organization.5 Recent studies revealed that Pap-smear coverage does not correlate with trends of cervical cancer mortality in Latin America; ...
http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342011000600002
NewYork-Presbyterian Queens - Cancer Types - Cervical Cancer
If abnormal cells on the surface of the cervix spread deeper into the cervix, or to other tissues or organs, the disease is then called cervical cancer, or invasive cervical cancer. Cervical cancer occurs most often in women younger than the age of 50. It is different from cancer that begins in other parts of the uterus and requires different treatment. Most cervical cancers are squamous cell carcinomas and adenocarcinomas.. The mortality rates for cervical cancer have declined sharply as Pap screenings have become more prevalent. According to the American Cancer Society about 12,170 cases of invasive cervical cancer will be diagnosed in the U.S. during 2012. Some researchers estimate that noninvasive cervical cancer (also referred to as carcinoma in situ) is nearly four times more common than invasive cervical cancer.. ...
http://www.nyhq.org/diw/Content.asp?PageID=DIW007153&language=Korean
Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe? | Bentham...Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe? | Bentham...
Title:Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?. VOLUME: 19 ISSUE: 8. Author(s):Lucija Tomljenovic, Jean Pierre Spinosa and Christopher A. Shaw. Affiliation:Neural Dynamics Research Group, Department of Ophthalmology and Visual Sciences, University of British Columbia, 828 W. 10th Ave, Vancouver, BC, V5Z 1L8, Canada.. Keywords:HPV vaccines, Gardasil, Cervarix, adverse reactions, vaccine efficacy, vaccine safety, conflict of interests, clinical trials, cervical cancers, safety profile. Abstract:We carried out a systematic review of HPV vaccine pre- and post-licensure trials to assess the evidence of their effectiveness and safety. We find that HPV vaccine clinical trials design, and data interpretation of both efficacy and safety outcomes, were largely inadequate. Additionally, we note evidence of selective reporting of results from clinical trials (i.e., exclusion of vaccine efficacy figures related to study subgroups in ...
http://www.eurekaselect.com/106059/article?tracking-code=4
CMU Intellectual Repository: Prognostic evaluation of tumor-stroma ratio in patients with early stage cervical adenocarcinoma...CMU Intellectual Repository: Prognostic evaluation of tumor-stroma ratio in patients with early stage cervical adenocarcinoma...
Background: The tumor-stroma ratio (TSR) represents the percentage of neoplastic cell components compared to the combined area of neoplastic cells and the surrounding tumor-induced stroma. A low TSR (predomination of stromal component) has been demonstrated to be an independent adverse prognostic factor in cancers of several organs. In cervical carcinoma patients, TSR has been evaluated in only one previous study with different histological types. The present study aimed to assess the prognostic value of TSR in early stage cervical cancer patients with adenocarcinoma histology only. Materials and Methods: Histological slides of patients with early stage (IB-IIA) cervical adenocarcinoma who underwent surgical treatment between January 2003 and December 2011 were reviewed. Patients who had received preoperative chemotherapy were excluded. TSR was categorized as low (,50%) and high (≥50%). Correlations between TSR and clinicopathological variables were evaluated. Prognostic values of TSR and ...
http://cmuir.cmu.ac.th/handle/6653943832/54178?mode=full
Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma<...Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma<...
TY - JOUR. T1 - Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. AU - Runowicz, Carolyn D.. AU - Wadler, Scott. AU - Rodriguez-Rodriguez, Lorna. AU - Litwin, Peter. AU - Shaves, Mark. AU - OHanlan, Katherine A.. AU - Goldberg, Gary L.. AU - Tomainov, Catherine T.. AU - Byrnes, Richard. PY - 1989/9. Y1 - 1989/9. N2 - Patients with locally advanced cervical cancer have a poor prognosis. The efficacy of radiotherapy is limited by the presence of large tumor volume and nodal disease. As cisplatin is a documented radiosensitizer and has activity in squamous cell carcinomas, a prospective study was designed to evaluate the toxicity and potential synergism of concurrent cisplatin (20 mg/m2 × 5 d every 21 days) and radiotherapy in locally advanced cervical cancer. Forty-three patients were studied, of which 14 were stage IB/IIA (bulky disease) and 29 were stage IIB/IIIB/IVA. Of the 32 evaluable patients, there were 29 complete responders. Of these 29 patients, 27 remain ...
https://einstein.pure.elsevier.com/en/publications/concomitant-cisplatin-and-radiotherapy-in-locally-advanced-cervic-2
CellNetworks - Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Colombia
Extensive experimental and limited epidemiologic data suggest that adeno-associated viruses (AAV) can have antioncogenic activity and may be protective factors for the development of cervical cancer. To examine the association between AAV-2 IgG antibodies and cervical neoplasia in Spain and Colombia, we tested for AAV-2 antibodies using an ELISA assay for 109 women with invasive cervical cancer, 100 population-based controls age-matched to the invasive cases, 77 women with carcinoma in situ (CIN III) and 100 clinic-based controls age-matched to the CIN III cases. Human papillomavirus (HPV) DNA was detected in cervical exfoliated cells by polymerase chain reaction using HPV-L1 and GP5+/6+ consensus primers. The prevalence of AAV-2 antibody titers >100 was significantly lower in invasive cervical cancer cases than control participants. When comparing women with invasive cancer with controls or with CIN III cases, a pattern of decreasing cervical cancer risk with increasing AAV-2 titers was ...
http://www.cellnetworks.uni-hd.de/126288/Adeno-associated_virus_seropositivity_and_HPV-induced_cervical_cancer_in_Spain_and_Colombia_
LRIG1 and squamous epithelial uterine cervical cancer : correlation to prognosis, other tumor markers, sex steroid hormones,...LRIG1 and squamous epithelial uterine cervical cancer : correlation to prognosis, other tumor markers, sex steroid hormones,...
Cervical cancer is the second most common malignancy in women worldwide and one of the leading causes of cancer mortality globally. In patients with invasive cervical cancer prognostic factors are of value for the choice of treatment, monitoring of treatment and follow-up. The most important clinical prognostic factors are stage, tumor volume, parametrial infiltration, vascular invasion, lymph node metastases, and distant metastases. An improved estimation of the prognosis of cervical cancer is desirable, especially in early cancer stages.. The aim of this research was to study possible associations between tumor markers, female sex steroids, smoking, S-phase fraction (SPF), and prognosis in invasive squamous cell cervical cancer (SCC). The study comprised 190 patients with SCC, stages IB-IV, admitted to the Department of Gynecologic Oncology at Norrland University Hospital in Umeå between September 1984 and October1990. Ten year mortality was estimated.. In study I, of a total of 103 patients, ...
http://umu.diva-portal.org/smash/record.jsf?pid=diva2:148924
Ways HIV infection and cervical cancer are linked - ArchydeWays HIV infection and cervical cancer are linked - Archyde
The aim of the study was to calculate the proportion of women living with HIV among women with cervical cancer. The authors found that 5.8 percent of all new cervical cancer cases worldwide in 2018 were diagnosed in women with HIV infection. This corresponds to 33,000 cases per year, 85 percent of which occur in sub-Saharan Africa.. On the basis of the results, the team was also able to show that women with HIV are six times more likely to develop cervical cancer than women without HIV infection.. The association between cervical cancer and HIV is obvious, explains Prof. Dr. Dr. Andrea S. Winkler, Co-Head of the Center for Global Health. Cervical carcinomas are mostly caused by infections with human papillomavirus (HPV), which, like HIV, are sexually transmitted. Based on our results, one could assume that infection with HIV is a risk factor for infection with HPV. . South and East Africa are hardest hit. The regions of South and East Africa are hardest hit, with 63.8 percent (South Africa) ...
https://www.archyde.com/ways-hiv-infection-and-cervical-cancer-are-linked/
Adenocarcinoma of the Uterine Cervix<...
TY - JOUR. T1 - Adenocarcinoma of the Uterine Cervix. AU - Jerant, Anthony F. PY - 1997. Y1 - 1997. N2 - Background: Adenocarcinoma of the uterine cervix is an increasingly common cervical neoplasm that has received little attention in the primary care literature. The purpose of this paper is to describe an illustrative case that provides an excellent opportunity to review the symptoms, diagnostic pitfalls, treatment options, and prognosis of this important disease. Methods: Case report is described, along with results of a literature review using MEDLINE and pertinent references from retrieved articles. Results: The relative incidence of cervical adenocarcinoma has risen from 5 to 10 percent of all cervical neoplasms in the 1950s to 10 to 20 percent in recent series. Some studies have also reported an increasing absolute incidence linked to widespread oral contraceptive use. The diethylstilbestrol-associated clear-cell variant accounts for only 2 to 3 percent of cases. About 10 percent of ...
https://ucdavis.pure.elsevier.com/en/publications/adenocarcinoma-of-the-uterine-cervix
Cervical Cancer AwarenessCervical Cancer Awareness
This January, Care to Care is proud to participate in National Cervical Health Awareness Month. Cervical cancer was once one of the most common causes of cancer death for women. However, the cervical cancer death rate has gone down by more than 50% over the last 40 years, mainly due to the increased use of the Pap test for screening and early detection. This amazing screening tool can find changes in the cervix before cancer ever develops, enabling doctors to treat pre-cancerous states. Unfortunately, not all women are getting screened. In 2012, 10% of US women ages 21-65 reported they had not been screened for cervical cancer in the last 5 years. According to the American Cancer Society (ACS), there will be an estimated 12,820 new cases of invasive cervical cancer diagnosed in 2017, with an estimated 4,210 deaths from the disease.. Another important fact that many may not know is that most cervical cancers are preventable! Nearly all cases of cervical cancers are caused by human papillomavirus ...
http://blog.caretocare.com/2017/01/cervical-cancer-awareness/
Quantitative human papillomavirus type 16 viral load and prognosis of cervical cancer treatment efficiencyQuantitative human papillomavirus type 16 viral load and prognosis of cervical cancer treatment efficiency
Quantitative human papillomavirus type 16 viral load and prognosis of cervical cancer treatment efficiency is considered in the article.
http://radiation-and-risk.com/en/year2011-en/issue2/744-6
Cervical Cancer Awareness Month: Highlighting cervical cancer research at BMC - On MedicineCervical Cancer Awareness Month: Highlighting cervical cancer research at BMC - On Medicine
January marks Cervical Cancer Awareness Month and, in recognition of this, we are proud to present a range of some of the latest cervical cancer research published across BMCs oncology journals.. Despite being highly preventable through early screening methods and vaccination, cervical cancer remains the fourth most common cause of cancer among women worldwide.. Research into cervical cancer prevention, diagnostics, signaling pathways, and therapeutics is therefore crucial. The articles in this compilation have been curated by our cancer journal Editors and include the latest cervical cancer research from BMC in each of these four critical topics.. Cervical cancer prevention. ...
https://blogs.biomedcentral.com/on-medicine/2019/01/07/cervical-cancer-awareness-month-highlighting-cervical-cancer-research-bmc/
P16P16
... infection and neoplasms of cervical origin. The majority of SCCs of uterine cervix express p16. However, p16 can be expressed ... p16 can be used as a biomarker to improve the histological diagnostic accuracy of grade 3 cervical intraepithelial neoplasia ( ... p16 immunohistochemical expression alone cannot be used to discriminate between SCCs arising from uterine cervix versus urinary ... CIN). p16 is also implicated in the prevention of melanoma, oropharyngeal squamous cell carcinoma, cervical cancer, vulvar ...
https://en.wikipedia.org/wiki/P16
MORT (long non-coding RNA)MORT (long non-coding RNA)
... and Uterine Corpus Endometrial Carcinoma. MORT is silenced in cervical cancer and therefore may serve as an independent ... lymphoid neoplasm diffuse large B-cell lymphoma, pancreatic adenocarcinoma, rectum adenocarcinoma, skin cutaneous melanoma, ... Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer ...
https://en.wikipedia.org/wiki/MORT_(long_non-coding_RNA)
Florid cutaneous papillomatosisFlorid cutaneous papillomatosis
... uterine cancer, prostate cancer[citation needed], lung cancer and cervical cancer. Other associated underlying malignancies ... It is likely directly induced by an underlying neoplasm secreting a growth factor. One candidate may be alpha-transforming ... Acanthosis Nigricans and Florid Cutaneous Papillomatosis in a Patient with Metastatic Cervical Cancer", Dermatol Sin, 22: 142- ...
https://en.wikipedia.org/wiki/Florid_cutaneous_papillomatosis
Urogenital neoplasmUrogenital neoplasm
Types include: Cancer of the female genital organs: (Cervical cancer, Endometrial cancer, Ovarian cancer, Uterine cancer, ... A urogenital neoplasm is a tumor of the urogenital system. ... Neoplasm stubs, Disease stubs, Genitourinary system stubs). ...
https://en.wikipedia.org/wiki/Urogenital_neoplasm
HematometraHematometra
... and cervical cancer. Additionally, hematometra may develop as a complication of uterine or cervical surgery such as endometrial ... a biopsy of endometrial tissue can be taken to test for the presence of a neoplasm (cancer). Antibiotics may be given as ... Hematometra is usually treated by surgical cervical dilation to drain the blood from the uterus. Other treatments target the ... Other causes are acquired, such as cervical stenosis, intrauterine adhesions, endometrial cancer, ...
https://en.wikipedia.org/wiki/Hematometra
Adolf GusserowAdolf Gusserow
In 1870 Gusserow was the first physician to describe a rare type of uterine cervical adenocarcinoma that is sometimes referred ... Among his better written efforts was Die Neubildungen des Uterus (Neoplasms of the uterus). Zur Lehre vom Stoffwechsel des ... Cytologic and Cytochemical features of Adenoma Malignum of the Uterine Cervix Libri.de (short biography of Adolf Gusserow) ( ...
https://en.wikipedia.org/wiki/Adolf_Gusserow
AdenosarcomaAdenosarcoma
Symptoms of cervical adenosarcoma, like uterine adenosarcoma, are characterized by abnormal bleeding. Treatment mainly consists ... Malignant neoplasms arising in endometriosis: clinicopathological study of 14 cases. Clin Exp Obstet Gynecol. 2004;31(4):302-4 ... Uterine adenosarcoma are a subtype of uterine sarcomas. Uterine sarcomas account for 3 to 9% of uterine cancers, and 5.5 to 9% ... Uterine adenosarcoma commonly arise from the endometrium. Uterine adenosarcomas have the highest incidence in perimenopausal ...
https://en.wikipedia.org/wiki/Adenosarcoma
Cervical cancerCervical cancer
Myung SK, Ju W, Kim SC, Kim H (October 2011). "Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a ... "Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer". American ... Stage 1A cervical cancer Stage 1B cervical cancer Stage 2A cervical cancer Stage 2B cervical cancer Stage 3B cervical cancer ... Cervical intraepithelial neoplasia, the potential precursor to cervical cancer, is often diagnosed on examination of cervical ...
https://en.wikipedia.org/wiki/Cervical_cancer
DyskaryosisDyskaryosis
Cervical dyskaryosis is classified into three degrees of severity: mild dyskaryosis, moderate and severe. A further category is ... This may be followed by the development of a malignant neoplasm. Dyskaryosis is used synonymously with dysplasia, which is the ... ". "Dyskaryosis" is a term used for all squamous mucosal surfaces and commonly used for the uterine cervix condition in which ... Dyskaryosis means abnormal nucleus and refers to the abnormal epithelial cell which may be found in cervical sample. It is ...
https://en.wikipedia.org/wiki/Dyskaryosis
List of MeSH codes (C13)List of MeSH codes (C13)
... uterine cervical incompetence MeSH C13.371.852.150.131 - uterine cervical neoplasms MeSH C13.371.852.150.150 - uterine ... uterine cervical diseases MeSH C13.371.852.150.074 - uterine cervical dysplasia MeSH C13.371.852.150.112 - uterine cervical ... uterine cervical neoplasms MeSH C13.371.852.833 - uterine prolapse MeSH C13.371.852.904 - uterine rupture MeSH C13.371.852.904. ... uterine cervical neoplasms MeSH C13.371.820.800.418.937 - vaginal neoplasms MeSH C13.371.820.800.418.968 - vulvar neoplasms ...
https://en.wikipedia.org/wiki/List_of_MeSH_codes_(C13)
Glassy cell carcinoma of the cervixGlassy cell carcinoma of the cervix
"Uterine Neoplasms". Journal of the National Comprehensive Cancer Network. 7 (5): 498-531. doi:10.6004/jnccn.2009.0035. ISSN ... Cervix Cervical cancer Villoglandular adenocarcinoma Low mag. High mag. Nasu, K.; Takai, N.; Narahara, H. (Jun 2009). " ... 2004). "Glassy cell carcinoma of the uterine cervix a rare histology. Report of three cases with a review of the literature". ... Glassy cell carcinoma of the cervix, also glassy cell carcinoma, is a rare aggressive malignant tumour of the uterine cervix. ...
https://en.wikipedia.org/wiki/Glassy_cell_carcinoma_of_the_cervix
List of cancer typesList of cancer types
... islet cell Rectal cancer Small intestine cancer Bladder cancer Cervical cancer Endometrial cancer Extragonadal germ cell tumor ... transitional cell cancer Urethral cancer Uterine sarcoma Vaginal cancer Vulvar cancer Wilms tumor (nephroblastoma) Esophageal ... Marginal zone B-cell lymphoma Mast cell leukemia Mediastinal large B cell lymphoma Multiple myeloma/plasma cell neoplasm ...
https://en.wikipedia.org/wiki/List_of_cancer_types
Carcinoma in situCarcinoma in situ
Cervical squamous intraepithelial lesion (SIL), previously called cervical intraepithelial neoplasia (CIN), is a form of ... Dysplasia of the uterine cervix is removed by excision (cutting it out) or by burning with a laser. Bowen's disease of the skin ... While they are a form of neoplasm, there is disagreement over whether CIS should be classified as cancer. This controversy also ... "Understanding Cervical Changes" (PDF). National Cancer Institute. National Institute of Health. Retrieved 17 June 2014.[ ...
https://en.wikipedia.org/wiki/Carcinoma_in_situ
Obstetrical bleedingObstetrical bleeding
... neoplasm, most commonly cervical cancer, and hematologic disorders. Molar pregnancy (also called hydatiform mole) is a type of ... Besides placenta previa and placental abruption, uterine rupture can occur, which is a very serious condition leading to ... As well as cervical insufficiency defined as a midtrimester (14th-26th week) dilation of the cervix which may need medical ... Causes of bleeding before and during childbirth include cervicitis, placenta previa, placental abruption and uterine rupture. ...
https://en.wikipedia.org/wiki/Obstetrical_bleeding
MAGEA4MAGEA4
2003). "Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma". Oncology. 64 (4): 443-9. ... "Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms". Clinical Cancer Research. 9 (17): ... "Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinosarcomas and papillary serous carcinomas". ...
https://en.wikipedia.org/wiki/MAGEA4
List of MeSH codes (C04)List of MeSH codes (C04)
... uterine cervical neoplasms MeSH C04.588.945.418.955 - vaginal neoplasms MeSH C04.588.945.418.968 - vulvar neoplasms MeSH ... genital neoplasms, female MeSH C04.588.945.418.365 - fallopian tube neoplasms MeSH C04.588.945.418.948 - uterine neoplasms MeSH ... skull base neoplasms MeSH C04.588.149.828 - spinal neoplasms MeSH C04.588.180.260 - breast neoplasms, male MeSH C04.588.180.390 ... bile duct neoplasms MeSH C04.588.274.120.250.250 - common bile duct neoplasms MeSH C04.588.274.120.401 - gallbladder neoplasms ...
https://en.wikipedia.org/wiki/List_of_MeSH_codes_(C04)
Small-cell carcinomaSmall-cell carcinoma
Brown-Séquard syndrome Cervical cancer "small-cell carcinoma" at Dorland's Medical Dictionary Nasu K, Hirakawa T, Okamoto M, ... Small-cell carcinoma is an undifferentiated neoplasm composed of primitive-appearing cells. As the name implies, the cells in ... March 2011). "Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and ...
https://en.wikipedia.org/wiki/Small-cell_carcinoma
Polyp (medicine)Polyp (medicine)
A cervical polyp is a common benign polyp or tumor on the surface of the cervical canal. They can cause irregular menstrual ... Some polyps are tumors (neoplasms) and others are non-neoplastic, for example hyperplastic or dysplastic, which are benign. The ... ISBN 978-1-900151-51-1. "Uterine polyps". MayoClinic.com. 2006-04-27. Retrieved 2007-10-20. Sternberg, Stephen S.; Stacey E. ... An endometrial polyp or uterine polyp is a polyp or lesion in the lining of the uterus (endometrium) that takes up space within ...
https://en.wikipedia.org/wiki/Polyp_(medicine)
List of skin conditionsList of skin conditions
... neoplasms, and cysts are skin lesions that develop from the epidermal layer of the skin. Aberrant basal cell carcinoma ... cervical accessory tragus, wattle) Congenital erosive and vesicular dermatosis Congenital hypertrophy of the lateral fold of ... Multinucleate cell angiohistocytoma Multiple cutaneous and uterine leiomyomatosis syndrome (leiomyomatosis cutis et uteri, ... an overview with emphasis on the myeloid neoplasms". Chem. Biol. Interact. 184 (1-2): 16-20. doi:10.1016/j.cbi.2009.10.009. ...
https://en.wikipedia.org/wiki/List_of_skin_conditions
UterusUterus
... inflammation of the muscular uterine wall. Uterine malformations are mainly congenital malformations, and include uterine ... Prolapse of the uterus Carcinoma of the cervix - malignant neoplasm Carcinoma of the uterus - malignant neoplasm Fibroids - ... "Cervical Stenosis - Women's Health Issues - Merck Manuals Consumer Version". Merck Manuals Consumer Version. Archived from the ... During pregnancy, the uterine glands and blood vessels in the endometrium further increase in size and number and form the ...
https://en.wikipedia.org/wiki/Uterus
BrachytherapyBrachytherapy
14 Cervical cancer can be treated with either LDR, PDR or HDR brachytherapy. Used in combination with EBRT, brachytherapy can ... GammaTile is FDA-cleared to treat newly diagnosed, operable malignant intracranial neoplasms (i.e., brain tumors) and operable ... "High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix". Cancer. 94 (1): 117-124. doi: ... Brachytherapy is commonly used in the treatment of early or locally confined cervical cancer and is a standard of care in many ...
https://en.wikipedia.org/wiki/Brachytherapy
Fibroblast activation protein, alphaFibroblast activation protein, alpha
... in cervical carcinoma and cervical intraepithelial neoplasm". Anticancer Research. 23 (4): 3195-8. PMID 12926053. Iwasa S, Jin ... and uterine stroma. FAP expression is high in reactive stromal fibroblasts of epithelial cancers, granulation tissue of healing ...
https://en.wikipedia.org/wiki/Fibroblast_activation_protein,_alpha
Glossary of medicineGlossary of medicine
The narrow, central cervical canal runs along its entire length, connecting the uterine cavity and the lumen of the vagina. The ... Papillary - In oncology, papillary refers to neoplasms with projections ("papillae", from Latin, 'nipple') that have ... Cervical cancer - is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to ... Brachial plexus - is a network of nerves formed by the ventral rami of the lower four cervical nerves and first thoracic nerve ...
https://en.wikipedia.org/wiki/Glossary_of_medicine
Interventional radiologyInterventional radiology
Uterine artery embolization (UAE) or uterine fibroid embolization (UFE) Prostate artery embolization (PAE) Pulmonary ... Used to treat patients with radicular symptoms in the cervical, thoracic, lumbar or sacral region. Helps to alleviate pain by ... such as osteoporosis or underlying neoplasm. Analogous to vertebroplasty, the purpose of sacroplasty is to provide ...
https://en.wikipedia.org/wiki/Interventional_radiology
Ovarian cancerOvarian cancer
They can develop further into a variety of other neoplasms, including choriocarcinoma, yolk sac tumor, and teratoma. They occur ... Histologically, they are similar to intestinal or cervical adenocarcinomas and are often actually metastases of appendiceal or ... CA-125 may also be elevated in benign (non-cancerous) conditions, including endometriosis, pregnancy, uterine fibroids, ... More typically, ovarian squamous cell carcinomas are cervical metastases, areas of differentiation in an endometrioid tumor, or ...
https://en.wikipedia.org/wiki/Ovarian_cancer
Estrogen (medication)Estrogen (medication)
... in treatment of infertility in women when there is a need to develop sperm-friendly cervical mucous or an appropriate uterine ... "Pharmacology and Clinical Utility of Hormones in Hormone Related Neoplasms". In Alan C. Sartorelli, David G. Johns (eds.). ...
https://en.wikipedia.org/wiki/Estrogen_(medication)
HysterectomyHysterectomy
Uterus prior to hysterectomy Laparoscopical hysterectomy Cervical stump (white) after removal of the uterine corpus at ... "Peritoneal Dissemination Complicating Morcellation of Uterine Mesenchymal Neoplasms". PLOS ONE. 7 (11): e50058. Bibcode: ... where the uterine lining has grown into and sometimes through the uterine wall musculature. This can thicken the uterine walls ... "Uterine Adenomyosis". Yale Medicine. Retrieved 2022-10-31. Uterine fibroids: Overview. Institute for Quality and Efficiency in ...
https://en.wikipedia.org/wiki/Hysterectomy
CancerCancer
They form a subset of neoplasms. A neoplasm or tumor is a group of cells that have undergone unregulated growth and will often ... Cervical cancer may require birth by Caesarean section. Radiation to the breast reduces the ability of that breast to produce ... In a few instances, such as advanced uterine cancer, the pregnancy cannot be continued and in others, the patient may end the ... It is used to treat basal cell skin cancer and the very early stages of others like cervical, penile, vaginal, vulvar, and non- ...
https://en.wikipedia.org/wiki/Cancer
Uterine fibroidUterine fibroid
Benign neoplasms, Wikipedia medicine articles ready to translate, Uterine tumour). ... Cervical fibroids are located in the wall of the cervix (neck of the uterus). Rarely, fibroids are found in the supporting ... The prevalence of uterine fibroids among teenagers is 0.4%. The incidence of uterine fibroids in Europe is thought to be lower ... Uterine fibroids, also known as uterine leiomyomas or fibroids, are benign smooth muscle tumors of the uterus. Most women with ...
https://en.wikipedia.org/wiki/Uterine_fibroid
Details for: Cervical cancer screening in developing countries : › WHO HQ Library catalogDetails for: Cervical cancer screening in developing countries : › WHO HQ Library catalog
Uterine cervical neoplasms -- diagnosis -- cytology , Diagnostic techniques, Obstetrical and gynecological -- utilization , ... Cervical cancer screening in developing countries : report of a WHO consultation. By: WHO Consultation on Cervical Cancer ...
https://kohahq.searo.who.int/cgi-bin/koha/opac-search.pl?q=ccl=su:{DNA probes}&sort_by=relevance_dsc&count=20&limit=location:READING-RM
Browsing Publications by Subject Uterine Cervical NeoplasmsBrowsing Publications by Subject "Uterine Cervical Neoplasms"
... 0-9. A. B. C. D. E. F. G. H. I. J. K. L. M. N. O. P. Q. R. S. T ... Persistent infection with oncogenic HPV types can cause cervical cancer in women and ... ...
https://apps.who.int/iris/handle/10665/107132/browse?authority=Uterine+Cervical+Neoplasms&type=mesh
Ver por tema Uterine Cervical NeoplasmsVer por tema "Uterine Cervical Neoplasms"
Accelerating cervical cancer elimination: report by the Director-General  Executive Board, 144 (‎World Health Organization, ... Advocacy for cervical cancer prevention and control in Africa: facilitator manual  World Health Organization. Regional Office ... Accelerating the elimination of cervical cancer as a global public health problem: report by the Director-General  ... Accelerating the elimination of cervical cancer as a global public health problem: draft decision proposed by Australia, Brazil ...
https://extranet.who.int/iris/restricted/browse?locale-attribute=pt&type=mesh&authority=Uterine+Cervical+Neoplasms
Results of search for 'su:{Uterine Cervical Neoplasms}' › WHO HQ Library catalog
Results of search for su:{Uterine Cervical Neoplasms} Refine your search. *. Availability. * Limit to currently available ... Screening for cancer of the uterine cervix / from the IARC Working Group on Cervical Cancer Screening and the UICC Project ... Second cancer in relation to radiation treatment for cervical cancer / from the International Radiation Study Group on Cervical ... Cervical screening : a practical guide / Ann McPherson. by McPherson, Ann.. Material type: Text; Format: print Publication ...
https://kohahq.searo.who.int/cgi-bin/koha/opac-search.pl?q=su:%7BUterine%20Cervical%20Neoplasms%7D
UTERINE CERVICAL NEOPLASMS | SelfDecode | Genome AnalysisUTERINE CERVICAL NEOPLASMS | SelfDecode | Genome Analysis
Use SelfDecode to get personalized health recommendations based on your genes. Get started today with an existing DNA file or order a SelfDecode DNA kit!
https://selfdecode.com/disease/uterine-cervical-neoplasms/
Cervical Cancer | HPV | Human Papillomavirus | MedlinePlusCervical Cancer | HPV | Human Papillomavirus | MedlinePlus
Most cervical cancer is caused by the HPV virus. It can often be cured if found early - learn how. ... ClinicalTrials.gov: Uterine Cervical Neoplasms (National Institutes of Health) Journal Articles References and abstracts from ... Cervical Cancer Symptoms (National Cancer Institute) Also in Spanish * Signs and Symptoms of Cervical Cancer (American Cancer ... Cervical Cancer Stages (National Cancer Institute) Also in Spanish * How Is Cervical Cancer Diagnosed? (American Cancer Society ...
https://medlineplus.gov/cervicalcancer.html
Cancer du col de lutérusCancer du col de l'utérus
Uterine Cervical Neoplasms. en_US. dc.title. Cancer du col de lutérus. en_US. ...
https://extranet.who.int/iris/restricted/handle/10665/363327?show=full
DeCS 2006 - Changed termsDeCS 2006 - Changed terms
C04 - Neoplasms. Cervix Dysplasia. Uterine Cervical Dysplasia. Cervix Neoplasms. Uterine Cervical Neoplasms. ...
https://decs.bvs.br/I/rep_i2006.htm
Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric...Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric...
Long-term use of oral contraceptives could be a cofactor that increases risk of cervical carcinoma by up to four-fold in women ... who are positive for cervical HPV DNA. In the absence of worldwide information about HPV status, extra effort should be made to ... Uterine Cervical Neoplasms / chemically induced * Uterine Cervical Neoplasms / etiology* Substances * Contraceptives, Oral, ... We aimed to assess how use of oral contraceptives affected risk of cervical cancer in women who tested positive for HPV DNA. ...
https://pubmed.ncbi.nlm.nih.gov/11943255/
AdvanTIG-202: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody...AdvanTIG-202: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody...
Uterine Cervical Neoplasms. Uterine Neoplasms. Genital Neoplasms, Female. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. ... Assessment of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Cervical Cancer ... in Participants With Previously Treated Recurrent or Metastatic Cervical Cancer. The safety and scientific validity of this ... in participants with previously treated recurrent or metastatic cervical cancer. ...
https://clinicaltrials.gov/ct2/show/NCT04693234
Multimedia | Portal Regional da BVSMultimedia | Portal Regional da BVS
Mouth Neoplasms 1 * Uterine Cervical Neoplasms 1 BIREME - PAHO - WHO. Latin American and Caribbean Center on Health Sciences ...
https://bvsalud.org/en/multimedia?q=&filter=media_type_filter%3A%22pt-br%5EImagem+animada%7Ces%5EImagen+animada%7Cen%5EAnimated+image%7Cfr%5EImage+anim%C3%A9e%22
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell FunctionCytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
Endometrial Neoplasms. *Uterine Cervical Neoplasms. *Adenoma. .map{width:100%;height:300px;margin-bottom:15px;} Name. Location ... human Cervical cancer (CC) by triple-color flow cytometry with combination of different. surface markers. We found up-regulated ...
http://www.knowcancer.com/cancer-trials/NCT00173290/
Subject: antineoplastic agents / Subject term: antineoplastic activity / Text Availability: Citation in PubAg - PubAg Search...Subject: antineoplastic agents / Subject term: antineoplastic activity / Text Availability: Citation in PubAg - PubAg Search...
... pancreatic neoplasms; pollution; research; soybeans; stomach neoplasms; temperature; uterine cervical neoplasms. Abstract:. ... neoplasm cells; stomach; therapeutics; thioredoxins; toxicity; uterine cervical neoplasms. Abstract:. ... Emerging studies ... colorectal neoplasms; comparative study; drug therapy; esophageal neoplasms; glutamine; human health; liver neoplasms; neoplasm ... antineoplastic activity; antineoplastic agents; biosynthesis; breast neoplasms; colorectal neoplasms; humans; lung neoplasms; ...
https://pubag.nal.usda.gov/?f%5Bsubject_facet%5D%5B%5D=antineoplastic+agents&f%5Bsubject_term%5D%5B%5D=antineoplastic+activity&f%5Btext_availability_facet%5D%5B%5D=Citation+in+PubAg&per_page=50&sort=relevance
Comprehensive Cervical Cancer Prevention in Tanzania - Publikationer - Syddansk UniversitetComprehensive Cervical Cancer Prevention in Tanzania - Publikationer - Syddansk Universitet
Uterine Cervical Neoplasms 76% * Nurses 40% * Africa South of the Sahara 30% ... Comprehensive Cervical Cancer Prevention in Tanzania (CONCEPT) study: Cohort profile. Mchome, B., Swai, P., Wu, C., Katanga, J. ... HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women ... Competing needs: A qualitative study of cervical cancer screening attendance among HPV-positive women in Tanzania. Linde, D. S. ...
https://portal.findresearcher.sdu.dk/da/projects/comprehensive-cervical-cancer-prevention-in-tanzania/publications/?type=%2Fdk%2Fatira%2Fpure%2Fresearchoutput%2Fresearchoutputtypes%2Fcontributiontojournal%2Farticle
Benign Cervical Lesions: Embryology, Anatomy, PhysiologyBenign Cervical Lesions: Embryology, Anatomy, Physiology
These benign neoplasms may originate in the cervix and account for approximately 8% of all uterine smooth muscle tumors. They ... These findings include the so-called cockscomb cervix, cervical rings, cervical collars, and cervical hoods. The cockscomb ... The major blood supply is from the descending branch of the uterine artery. Also contributing is the cervical branch of the ... The cervical leiomyoma is usually part of the spectrum of uterine smooth muscle tumors. ...
https://emedicine.medscape.com/article/264966-overview
Associations between religion-related factors and cervical cancer screening among muslims in greater chicago<...
Uterine Cervical Neoplasms Medicine & Life Sciences 69% * Punishment Medicine & Life Sciences 38% ... Padela AI, Peek M, Johnson C, Hosseinian Z, Curlin F. Associations between religion-related factors and cervical cancer ... Padela, AI, Peek, M, Johnson, C, Hosseinian, Z & Curlin, F 2014, Associations between religion-related factors and cervical ... Associations between religion-related factors and cervical cancer screening among muslims in greater chicago. In: Journal of ...
https://asu.pure.elsevier.com/en/publications/associations-between-religion-related-factors-and-cervical-cancer
Keith L Knutson - Research output - Mayo Clinic
Portal Regional da BVSPortal Regional da BVS
Breast Neoplasms, Vaginal Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, 50234, 50233, Nevi and ... Neoplasms, Medical Oncology, Oncology Service, Hospital, Oncology Nursing, Radiotherapy, Antineoplastic Protocols, ... Antineoplastic Combined Chemotherapy Protocols, Precancerous Conditions, Genetics, Genes, Neoplasm, Neoplastic Stem Cells, ... Genes, Tumor Suppressor, Cancer Symptoms, Biomarkers, Pharmacological, General Surgery, Lung, Lung Neoplasms, Gynecology, ...
https://bvsalud.org/en/direve/?filter=descriptor:%22Oncology%20Service,%20Hospital%22%20AND%20descriptor:%22Ovarian%20Neoplasms%22%20AND%20descriptor:%22Neoplastic%20Stem%20Cells%22%20AND%20descriptor:%22Oncology%20Service,%20Hospital%22%20AND%20descriptor:%22Medical%20Oncology%22%20AND%20descriptor:%22Lung%20Neoplasms%22%20AND%20descriptor:%22Radioterapia%22
Validation of a sustainable internationally monitored cervical cancer screening system using a visual smartphone inspection in...Validation of a sustainable internationally monitored cervical cancer screening system using a visual smartphone inspection in...
uterine cervical neoplasms. Data availability statement. Data are available upon reasonable request. ... Conclusions Cervical cancer screening through combined visual inspection, conducted by non-specialized personnel and monitored ... Objective To determine the sensitivity, specificity, and positive and negative predictive values of a cervical cancer screening ... Validation of a sustainable internationally monitored cervical cancer screening system using a visual smartphone inspection in ...
https://ijgc.bmj.com/content/early/2022/07/20/ijgc-2022-003592
The impact of preventive HPV vaccination.<...
Uterine Cervical Neoplasms Medicine & Life Sciences 55% * Public Health Medicine & Life Sciences 42% ... The clearly defined causation by papillomavirus (HPV) and precursor lesions of cervical cancer have made this cancer largely ... N2 - The clearly defined causation by papillomavirus (HPV) and precursor lesions of cervical cancer have made this cancer ... AB - The clearly defined causation by papillomavirus (HPV) and precursor lesions of cervical cancer have made this cancer ...
https://jhu.pure.elsevier.com/en/publications/the-impact-of-preventive-hpv-vaccination-4
Patient 1980,1981,1985,1989,1990Patient 1980,1981,1985,1989,1990
Benign Neoplasms 2140.0 Fibroids and other uterine neoplasms Includes: Myoma Leiomyomata Cervical polyp Nabothian cyst 2145.0 ... Neoplasms Malignant Neoplasms 2100.0 Cancer, gastrointestinal tract Includes: Esophagus Stomach Small intestine Colon 2105.0 ... neoplasm of bone. In other words, change the 20 to V. NOTE: The use of prefixes facilitates the calculation of percent ... Cervical spine, neck Includes: Whiplash 5110.0 Back 5115.0 Knee 5120.0 Ankle 5125.0 Wrist 5130.0 Sprain or strain, other and ...
https://wonder.cdc.gov/wonder/sci_data/surveys/namcs/type_txt/patients.asp
Drug 1990Drug 1990
Benign Neoplasms 2140.0 Fibroids and other uterine neoplasms Includes: Myoma Leiomyomata Cervical polyp Nabothian cyst 2145.0 ... Fibroids and other uterine neoplasms Includes: Myoma Leiomyomata Cervical polyp Nabothian cyst 2145.0 Other benign neoplasms ... Neoplasms Malignant Neoplasms 2100.0 Cancer, gastrointestinal tract Includes: Esophagus Stomach Small intestine Colon 2105.0 ... Sprains and strains: 5105.0 Cervical spine, neck Includes: Whiplash 5110.0 Back 5115.0 Knee 5120.0 Ankle 5125.0 Wrist 5130.0 ...
https://wonder.cdc.gov/wonder/sci_data/surveys/namcs/type_txt/drug90.asp
Combined electroacupuncture and auricular acupuncture for postoperative pain after abdominal surgery for gynecological diseases...Combined electroacupuncture and auricular acupuncture for postoperative pain after abdominal surgery for gynecological diseases...
... and cervical lesions, will be recruited. Seventy-two participants will be randomly allocated to an acupuncture or non-invasive ... Patients who are eligible for laparotomy with a midline incision for gynecological neoplasia, including ovarian mass, uterine ... Eligible for laparotomy with midline incision for gynecological neoplasm including ovarian mass, uterine mass, and cervical ... However, as wound pain is the main target of treatment, the variation of types of neoplasm would not be a great problem. To ...
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-017-2359-8
The AMEDEO Literature GuideThe AMEDEO Literature Guide
Uterine cervical neoplasms mass screening at the University Hospital Centre of Libreville, Gabon: Associated factors with ... Ranking lifestyle risk factors for cervical cancer among Black women: A case-control study from Johannesburg, South Africa.. ...
https://amedeo.com/medicine/smo/j1020.htm
Stephanie Melissa Smith | Stanford MedicineStephanie Melissa Smith | Stanford Medicine
Uterine Cervical Cancer, Vaginal Cancer, Vulvar Cancer, Trophoblastic Neoplasms, Pelvic Reconstructive Surgery, Neovagina, ... Cause-specific mortality was evaluated in eligible survivors (n = 568), and subsequent malignant neoplasms, chronic health ... Cause-specific mortality was evaluated in eligible survivors (n = 568), and subsequent malignant neoplasms, chronic health ... Cause-specific mortality was evaluated in eligible survivors (n = 568), and subsequent malignant neoplasms, chronic health ...
https://med.stanford.edu/profiles/stephanie-smith
The Expression of CD8+ and MHC-I in Cervical Cancer with HPV InfectionThe Expression of CD8+ and MHC-I in Cervical Cancer with HPV Infection
Neoplasm of the cervical uterine is the most common form neoplasm in women. This neoplasm is found in developing state as ... Cervical cancer is the most common form neoplasm in women. This neoplasm is found in developing state as leading cause of ... Now the pathogenesis of cervical cancer is focused to human papilloma virus (HPV) [1-3]. Immunity to neoplasm or cancer as a ... Immunity against uterine cancer played by MHC-I and CD8+ is in milt category. The experiment that related with uterine cancer ...
https://file.scirp.org/Html/3-8901613_31442.htm
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer<...
Uterine Cervical Neoplasms Medicine & Life Sciences 100% * Immunotherapy Medicine & Life Sciences 95% ... The incidences of cervical carcinoma and of high-grade dysplasia (CIN 3) were consequently reduced by comparison to control ... The incidences of cervical carcinoma and of high-grade dysplasia (CIN 3) were consequently reduced by comparison to control ... The incidences of cervical carcinoma and of high-grade dysplasia (CIN 3) were consequently reduced by comparison to control ...
https://moh-it.pure.elsevier.com/en/publications/cd4-t-cell-mediated-antigen-specific-immunotherapy-in-a-mouse-mod
Three-Year Survival after Lymphadenectomy for Residual Lymph Node Metastasis of Esophageal Cancer with Invasion into the...
Neoplasm Staging 20% * Uterine Cervical Neoplasms 17% * Cisplatin 16% * Therapeutics 12% * Neoplasms 12% ...
https://kyushu-u.pure.elsevier.com/en/publications/three-year-survival-after-lymphadenectomy-for-residual-lymph-node/fingerprints/
nsns
Uterine Cervical Neoplasms 2 * Violence Against Women 4 * Water Supply 3 * Womens Health 5 ...
https://stacks.cdc.gov/cbrowse?pid=cdc%3A8231&parentId=cdc%3A8231
MetastasisNeoplasiaLesionsIncidenceDysplasiaBenignVaginalUterusHysterectomyCarcinoma in SPreventionRisk of cervical cancerDevelopment of cervical cancerArtery embolizationAcetic acidSquamous CellCancersMalignantTumorLungOvarianAbnormalSymptomsHysteroscopyProspective studyAntibodiesLeiomyomaEarly Detection
Metastasis2
  • Uterine fibroids can also be life threatening via pulmonary metastasis or intravascular extension, despite being benign tumors ( 8 ). (spandidos-publications.com)
  • Differences in the integration pattern and episomal forms of human papillomavirus type 16 DNA found within an invasive cervical neoplasm and its metastasis. (omeka.net)
Neoplasia3
  • Tissue alterations due to these atrophic changes, trauma, erythema, and microvascularization can be confused with cervical intraepithelial neoplasia. (medscape.com)
  • Patients who are eligible for laparotomy with a midline incision for gynecological neoplasia, including ovarian mass, uterine mass, and cervical lesions, will be recruited. (biomedcentral.com)
  • Including men and boys in the program was the most effective strategy, reducing the incidence of genital warts, cervical intraepithelial neoplasia, and cervical cancer by 97%, 91%, and 91%, respectively. (cdc.gov)
Lesions3
  • Conclusions Cervical cancer screening through combined visual inspection, conducted by non-specialized personnel and monitored by experts through smartphones, shows encouraging results, ruling out high-grade cytological lesions in most cases. (bmj.com)
  • The clearly defined causation by papillomavirus (HPV) and precursor lesions of cervical cancer have made this cancer largely preventable through Pap screening programs, and now by vaccination with Gardasil. (elsevier.com)
  • IMSEAR at SEARO: Role of HSV antibodies in precancerous & cancerous lesions of the uterine cervix--a prospective study. (who.int)
Incidence5
  • Several approaches to reduce the incidence of invasive cervical cancers exist. (ox.ac.uk)
  • According to the Institute for Health Metrics and Evaluation, the prevalence, incidence and mortality of uterine fibroids worldwide in 2019 were 29, 0.24 and 0.002%, respectively ( 6 ). (spandidos-publications.com)
  • Linking cancer incidence data obtained from the Finnish Cancer Registry with this material yielded 32 cases of cervical cancer diagnosed after drawing of the blood sample. (ox.ac.uk)
  • Compared with current practice, vaccinating girls before the age of 12 years would reduce the incidence of genital warts (83%) and cervical cancer (78%) due to HPV 6/11/16/18. (cdc.gov)
  • Cervical cancer incidence and deaths have substantially decreased in countries with organized cervical cancer screening programs ( 2 ). (cdc.gov)
Dysplasia3
  • Cervical Dysplasia: Is It Cancer? (medlineplus.gov)
  • The incidences of cervical carcinoma and of high-grade dysplasia (CIN 3) were consequently reduced by comparison to control mice. (elsevier.com)
  • Cervical cancer and its dysplasia precursors account for significant morbidity and mortality in women worldwide. (elsevier.com)
Benign2
  • Should we perform cervix removal during hysterectomy for benign uterine disease? (bvsalud.org)
  • Uterine leiomyoma is the most common benign neoplasm of the female genital tract. (gafacom.website)
Vaginal3
  • Also contributing is the cervical branch of the vaginal artery. (medscape.com)
  • Presentation is non-specific and often includes abnormal vaginal bleeding and/or discharge, a cervical mass protruding from the vagina, abdominal and/or pelvic pain or, less commonly, difficulty passing stool and perianal pain. (cdc.gov)
  • This image depicts a colposcopic view of the vaginal interior, highlighting the cervical erosion that had taken place, due to what turned out to be low grade cervical carcinoma. (cdc.gov)
Uterus1
  • The opening of the cervical canal into the uterus is called the internal cervical os. (medscape.com)
Hysterectomy3
  • Multiple uterine fibroids and adenomyosis were detected and total hysterectomy was performed. (spandidos-publications.com)
  • Management of uterine fibroids includes observation, hormonal therapy, surgery (hysterectomy, myomectomy and trans-cervical resection), uterine artery embolization and high-frequency magnetic resonance-guided focused ultrasound surgery, with appropriate management varying from case to case ( 2-5 ). (spandidos-publications.com)
  • In patients who have undergone a radical hysterectomy, lymphovascular space invasion (LVSI), assessed on hematoxylin and eosin-stained slides, is a major factor for adjuvant therapy in patients with cervical cancer. (elsevier.com)
Carcinoma in S1
  • We pooled data from eight case-control studies of patients with histologically confirmed invasive cervical carcinoma (ICC) and from two studies of patients with carcinoma in situ (ISC). (nih.gov)
Prevention3
  • Thus, an HPV16 E7 immunogen holds promise for noninvasive treatment and prevention of human cervical cancer. (elsevier.com)
  • Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR. (ox.ac.uk)
  • To determine the cost-effectiveness of screening strategies combined with a vaccination program for 10-year old girls for cervical cancer prevention in Vientiane, Lao PDR. (ox.ac.uk)
Risk of cervical cancer2
  • We aimed to assess how use of oral contraceptives affected risk of cervical cancer in women who tested positive for HPV DNA. (nih.gov)
  • Background: The ability for women to self-collect human papillomavirus (HPV) samples can potentially reduce the risk of cervical cancer and increase screening coverage. (bvsalud.org)
Development of cervical cancer2
  • Human papillomavirus infection is common, preventable, and now widely accepted as the causative agent with oncogenic potential in the development of cervical cancer. (elsevier.com)
  • Human papillomaviruses (HPVs) play an important part in the development of cervical cancer, but the role of other infectious agents, such as herpes simplex virus (HSV), is not clear. (ox.ac.uk)
Artery embolization1
  • MRI can delineate intramural and submucous myomas accurately and is necessary prior to uterine artery embolization to assess blood flow to the fibroids. (gafacom.website)
Acetic acid1
  • Objective To determine the sensitivity, specificity, and positive and negative predictive values of a cervical cancer screening program based on visual inspection with acetic acid and Lugol's iodine using a smartphone in a sub-urban area of very low resources in Kinshasa (Democratic Republic of Congo). (bmj.com)
Squamous Cell3
  • Data from a hospital‐based case‐control study collected in 11 participating centers in 9 countries were analyzed to determine whether use of combined oral contraceptives alters risk of invasive squamous‐cell cervical cancer. (illinois.edu)
  • The relative risk of invasive squamous‐cell cervical carcinoma was estimated to be 1.31, with a 95% confidence interval that excluded one, in women who ever used combined oral contraceptives. (illinois.edu)
  • The strength of these results, and their consistency with those from other studies, suggest that a causal relationship may exist between use of combined oral contraceptives and squamous‐cell cervical carcinoma. (illinois.edu)
Cancers3
  • Cancers associés aux virus en Afrique. (who.int)
  • Introduction: The immunity against cervical cancers is many unknown. (scirp.org)
  • Most endometrial cancers are detected at an early stage, with the tumor confined to the uterine corpus in 75% of patients. (medscape.com)
Malignant1
  • Various histological subtypes (including dysgerminoma, yolk sac neoplasm, choriocarcinoma and malignant teratoma) are reported. (cdc.gov)
Tumor5
  • In our extended studies, we have directly examined the expressions of various inhibitory natural killer cell Receptors (iNKRs) on Tumor-infiltrating lymphocytes (TILs) derived from human Cervical cancer (CC) by triple-color flow cytometry with combination of different surface markers. (knowcancer.com)
  • TVS is superior to CT and approaches MRI in its ability to depict endometrial carcinoma and to provide information regarding myometrial, cervical, and, perhaps, parametrial tumor invasion. (medscape.com)
  • The primary cervical tumor contained large amounts of several distinct episomal forms as well as integrated HPV DNA. (omeka.net)
  • Acidic and basic fibroblast growth factor expression levels in cervical cancer and their effects on tumor cell proliferation. (geneticsmr.com)
  • It is a discrete, round, firm, often multiple uterine tumor composed of smooth muscle and connective tissue. (gafacom.website)
Lung1
  • Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). (nih.gov)
Ovarian4
  • Inainte papiloma humano laringe aparitia cancerului, celulele colului cervical se transforma, ovarian cancer jokes numit displazie, si devin celule anormale ale tesutului cervical. (etigararunway.ro)
  • Vinil parazitii bad joke Adenom clasifică nemathelminthes hewan coloid icd-9, Metastatic cancer neck icd 10 Uterine cancer awareness month Breast Cancer Ovarian cancer jokes Month - cancer cerebral estadio 4 Afecțiuni tratate Quick Search: To find out which conditions can be treated in a minimally invasive way by interventional radiologists, click on the corresponding section below. (etigararunway.ro)
  • Epithelial cystic tumors account for about 60% of all true ovarian neoplasms. (medscape.com)
  • Mucinous epithelial tumors account for approximately 10-15% of all epithelial ovarian neoplasms. (medscape.com)
Abnormal1
  • TVS is clinically established as the preferred technique for evaluation of endometrial disorders and is especially useful in the workup of abnormal uterine bleeding. (medscape.com)
Symptoms2
  • Cervical cancer may not cause any symptoms at first. (medlineplus.gov)
  • The two most common symptoms of uterine leiomyomas for which women seek treatment are AUB and pelvic pain or pressure. (gafacom.website)
Hysteroscopy1
  • Hysterography or hysteroscopy can also confirm cervical or submucous myomas. (gafacom.website)
Prospective study1
  • Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. (ox.ac.uk)
Antibodies4
  • Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. (ox.ac.uk)
  • HPV 16-E7 and/or HPV 18-E7 antibodies were significantly related to cervical cancer risk (RR 1.9, 95% CI 1.2-3.2). (ox.ac.uk)
  • Antibodies to HSV types 1 and 2, Chlamydia trachomatis, and to multiple infectious agents were associated with cervical cancer when seroprevalence rates in all cases and controls were compared, but when HPV-seropositive cases and controls were compared these associations were weaker and non-significant. (ox.ac.uk)
  • After adjustment for smoking and other sexually transmitted diseases, antibodies to C. trachomatis showed the strongest association with cervical cancer (odds ratio = 5.0 (95% confidence interval 1.6-15.7)), but the numbers were too small for drawing conclusions as to the sexually transmitted diseases with which cervical cancer is most specifically associated. (ox.ac.uk)
Leiomyoma1
Early Detection1
  • National Breast and Cervical Cancer Early Detection Program (NBCCEDP), focusing on expanding access to cancer survivors within the course of treatment, when feasible, an antiviral prescription. (sirisampadagroup.com)
Browsing Publications by Subject Uterine Cervical Neoplasms
Browsing Publications by Subject "Uterine Cervical Neoplasms" (apps.who.int)
Browsing EB146 by Subject Uterine Cervical Neoplasms
Browsing EB146 by Subject "Uterine Cervical Neoplasms" (apps.who.int)
Ver por tema Uterine Cervical Neoplasms
Ver por tema "Uterine Cervical Neoplasms" (extranet.who.int)
Browsing by Subject Uterine Cervical Neoplasms
Browsing by Subject "Uterine Cervical Neoplasms" (extranet.who.int)
Browsing Publications by Subject Uterine Cervical Neoplasms
Browsing Publications by Subject "Uterine Cervical Neoplasms" (extranet.who.int)
Browsing EB120 by Subject Uterine Cervical Neoplasms
Browsing EB120 by Subject "Uterine Cervical Neoplasms" (extranet.who.int)
Cervical Cancer | HPV | Human Papillomavirus | MedlinePlus
Cervical Cancer | HPV | Human Papillomavirus | MedlinePlus (medlineplus.gov)
Внедрение и расширение охвата тестированием на вирус папилломы человека в рамках комплексной программы по профилактике рака...
Внедрение и расширение охвата тестированием на вирус папилломы человека в рамках комплексной программы по профилактике рака... (apps.who.int)
Accélérer l'élimination du cancer du col de l'utérus en tant que problème de santé publique mondial
Accélérer l'élimination du cancer du col de l'utérus en tant que problème de santé publique mondial (apps.who.int)
Cervical cancer screening programmes : managerial guidelines / A. B. Miller
Cervical cancer screening programmes : managerial guidelines / A. B. Miller (apps.who.int)
Семьдесят вторая сессия Европейского регионального комитета: Тель-Авив, 12-14 сентября 2022 г.: Финансовые и административные...
Семьдесят вторая сессия Европейского регионального комитета: Тель-Авив, 12-14 сентября 2022 г.: Финансовые и административные... (apps.who.int)
Cervical cancer (‎Resolution)‎
Cervical cancer (‎Resolution)‎ (apps.who.int)
Browsing Regional Publications by Subject Uterine Cervical Neoplasms
Browsing Regional Publications by Subject "Uterine Cervical Neoplasms" (apps.who.int:80)
Browsing Regional Committee for Europe by Subject Uterine Cervical Neoplasms
Browsing Regional Committee for Europe by Subject "Uterine Cervical Neoplasms" (apps.who.int:80)
WHO framework for strengthening and scaling-up of services for the management of invasive cervical cancer
WHO framework for strengthening and scaling-up of services for the management of invasive cervical cancer (apps.who.int)
الاستراتيجية الإقليمية للتخلص من سرطان عنق الرحم
الاستراتيجية الإقليمية للتخلص من سرطان عنق الرحم (apps.who.int:80)
Accélérer l'élimination du cancer du col de l'utérus en tant que problème de santé publique mondial : projet de décision...
Accélérer l'élimination du cancer du col de l'utérus en tant que problème de santé publique mondial : projet de décision... (apps.who.int:80)
Stratégie régionale d'élimination du cancer du col de l'utérus
Stratégie régionale d'élimination du cancer du col de l'utérus (apps.who.int)